Fellowship Program Guide

Division of Nephrology and Hypertension

Harbor-UCLA Medical Center

July 1, 2018

2

Harbor-UCLA Medical Center Nephrology Fellowship Program THIS DOCUMENT SHOULD BE SEARCHED WITH THE “FIND” FUNCTION IN WORD.

Introduction

Fellow Selection Policy/Process

Faculty Members

Nephrology Fellowship Program Training Sites o Inpatient sites o Outpatient sites o Off-campus sites

Nephrology Training Program Schedule o Two Year Schedule o Monthly Schedule

Harbor-UCLA Medical Center Center for the Health Sciences at UCLA DaVita Torrance

Nephrology Clinical Training Program Curriculum - Overview o Clinical Curriculum Introduction o Overview of Clinical Program Goals and Objectives

Full Clinical Curriculum o Renal Structure and Function o Consult Nephrology o Renal Transplant o Dialysis and Extracorporeal Therapy o Special Areas

Log-in directions for the Monday afternoon Pathophysiology conference

Log-in directions for required LABiomed research modules https://www.citiprogram.org

o Transitions of Care policy Fellowship handoff agreement for academic year July 1, 2018-June 30, 2019

o Assessment and Evaluation of Attendings by Fellows o Self-evaluation by Fellows

Nephrology Research Training Program

Clinical Competency (Evaluation) Committee

Dealing with Unsatisfactory Fellow Performance

Guidelines for Promotion and Graduation

Program Evaluation Committee (PEC)

Nephrology Fellowship Work, Duty Hours, Moonlighting and On-Call Policy

o Instructions for forwarding pages from fellows to On-call attendings and back

Nephrology Fellow Stipend and Benefits

Policy on Fellow Teaching and Supervision of Residents

o The “Must call Attending list”

Faculty Research Interests

Publications by Faculty 2010-16

Nephrology Fellows Previous Ten Years 1. Introduction The Harbor-UCLA Medical Center Nephrology Fellowship Program is dedicated to providing the highest

quality clinical and research training in the subspecialty of Nephrology. It is accredited by the Graduate Medical Education Committee of the Harbor-UCLA Medical Center and by the Residency Review Committee of the ACGME. There are two programs:

1) The two year clinical program, chosen by the vast majority of our fellowship trainees, consists of 20

months of clinical experience and 4 months of research experience, inclusive of two months of vacation. It is designed to graduate trainees who will become Board Eligible in Nephrology. While this program provides primarily outstanding clinical training, in addition, the program is designed to provide both an appreciation and understanding of continuous quality improvement and research methodologies and an expectation that these experiences will result in presentations during Nephrology Grand Rounds by each senior fellow. For the research, most fellows additionally submit an abstract or manuscript. Fellows may choose an on-going faculty research project or be given an opportunity to develop related research interests of their own.

2) The three year research program. This program involves one year of clinical training and two

years of basic or clinical research. The clinical experience is structured so that it is similar to the clinical experience of a year in the two year clinical fellowship. The two years of research are spent under the direction of a faculty member within the Division of Nephrology and Hypertension. During the research years, up to 25% of the time is spent in clinical activities, which may include rounding on dialysis patients under the supervision of a faculty mentor. Individuals may also opt for research training in this track after having completed two clinical years.

This guide provides comprehensive information about all aspects of the Program, including, but not limited to:

Goals and objectives

Nature of sites where training is performed

Types of clinical encounters

Patient case-mix characteristics

Procedures and services

Educational activities and resources, including didactic training and conferences

Nature of supervision and evaluation of fellow’s performance

Handoff policies

Faculty research activities

Fellow research opportunities and policies

On-call and vacation policies

Duty hours policies

Former Fellow information

Fellow selection policy 2. Fellow Selection Policy/Process 1) To be eligible for a fellowship in the Division of Nephrology and Hypertension at the Harbor-UCLA

Medical Center, an applicant must: Be a graduate of a U.S. or Canadian medical school accredited by the Liaison Committee on

Medical Education (LCME) and have three years residency in an ACGME-approved program, OR Be a graduate of a U.S. or Canadian medical school accredited by the Liaison Committee on

Medical Education (LCME) and have two years residency in an ACGME-approved program, with approved fast-tracking for those interested in a subspecialty research career, OR

Be a graduate of a college of osteopathic medicine in the United States accredited by the

American Osteopathic Association (AOA) and have three years residency in an ACGME-approved program, OR

Be a graduate of a medical school outside of the United States who meets one or more of the

following qualifications:

a) Has a currently valid ECFMG certificate plus at least three years training in an ACGME approved program, OR

b) Has a currently valid ECFMG certificate plus at least two years training in an ACGME approved program, with approved fast-tracking for those interested in a subspecialty research career, OR

c) Has a full and unrestricted license to practice medicine in a US licensing jurisdiction plus at least one year training in an ACGME-approved program, OR

d) Is a graduate of a medical school outside the United States who has completed a Fifth Pathway program provided by an LCME-accredited medical school; OR

e) Be eligible for American Board of Internal Medicine certification prior to the time they begin Nephrology training

Nephrology fellows at Harbor-UCLA Medical Center must have an active medical license issued by

the California Board of Quality Assurance by the first day of the start of fellowship. 2) The Division of Nephrology and Hypertension will send an applicant (upon request): Introduction letter from the Division Chief and/or the Program Director General information about the Torrance area

Instructions on how to apply for the program through the Electronic Residency Application Service (ERAS) A statement that “The Harbor-UCLA Medical Center does not discriminate on the basis of sex, race, age, religion, color, national origin, disability, or veteran’s status”.

3) The Division of Nephrology and Hypertension requires the following documentation for application: -Completed fellowship application through ERAS -Curriculum Vitae and Personal Statement through ERAS

-Three letters of recommendation through ERAS -International Medical Graduates must include the following in addition to the above: - Copy of green card, visa (J-1), or documentation of U.S. citizenship - Valid ECFMG certificate with Clinical Skills Assessment certification - Evidence of previous training in the United States 4) Selection Criteria for Interviewing Applicants

Based on criteria developed jointly by the faculty, including USMLE board scores, letters of recommendation, and the quality of the applicant’s personal statement, and medical and residency training, applicants with applications submitted to ERAS are subsequently invited for an interview in accordance with the agreed-upon ERAS and Match timelines. On the interview day, applicants receive an information packet and interview with members of the Division of Nephrology and Hypertension and the Nephrology fellows. At the request of the applicant, interviews via Skype or FaceTime can be arranged. At the conclusion of the interview, the interviewers complete a standard evaluation form for each applicant they interviewed. The results are tallied and, together with the aforementioned data, form the basis of the preliminary rank order. The final rank order is determined based on an in-person meeting of the faculty, discussing each candidate’s strengths, weaknesses, and likelihood of adapting to our learning environment. The Harbor-UCLA Medical Center Nephrology program participates in the Match program for recruiting fellows.

5) The Harbor-UCLA Medical Center Graduate Medical Education Committee requires that fellows

have a California Medical License and ACLS certification. Fellows who are not currently certified in ACLS must become so within six months of commencing their training.

3. Division of Nephrology and Hypertension Faculty Members

Sharon Adler, M.D. Training Program Director, Professor of Medicine Research Interest: Diabetic kidney disease, CKD progression, peritoneal

dialysis membrane preservation, glomerulonephritis

Lilly Barba, M.D. Associate Professor of Medicine Medical Director of the Renal Transplant Program

Research interest: Renal transplantation

Zar Chan, MD Attending Physician Renal transplantation

Tiane Dai, M.D., Ph.D. Associate Professor of Medicine Research Interest: Peritoneal dialysis membrane preservation

Ramanath Dukkipati, M.D. Associate Professor of Medicine Research interest: Interventional nephrology, glomerulonephritis Joel Kopple, M.D. Professor of Medicine Research Interest: Nutritional aspects of CKD and ESRD; ESRD frailty, mortality and morbidity risk factors Hashim Mapara, M.D. Attending Physician Consultation Nephrology

Cynthia Nast, M.D. Professor of Pathology Research interest: Glomerular disease; Agricultural nephropathy; renal

pathology Madeleine Pahl, MD Professor of Medicine, UC Irvine Research interest: Renal transplantation, Microbiome in CKD/ESRD,

Genetics of DKD

Anuja Shah, M.D. Assistant Professor of Medicine Associate Training Program Director

Research Interest: Phosphorus balance and impact on mortality/morbidity

Jenny I. Shen, M.D. Assistant Professor of Medicine Research interest: Clinical epidemiology, patient-centered outcomes

research, clinical trials Lili Tong, M.D. Associate Professor Research interest: Diabetic kidney disease

4. Nephrology Fellowship Program Training Sites A. Inpatient sites (1) Harbor-UCLA Medical Center. This is a Los Angeles County operated inpatient and outpatient

medical facility serving the indigent population of southwestern LA County in a catchment area of approximately 2,000,000 population. Harbor-UCLA Medical Center operates approximately 350 inpatient beds containing surgical, neurosurgical, neonatal, pediatric, and medical intensive care units; a coronary care unit; an acute dialysis unit with support for hemodialysis, peritoneal dialysis, and continuous renal replacement therapies; a Renal Transplant unit; radiologic services with modern renal-related procedures and diagnostic vascular and radionucleotide imaging; microscopies for renal biopsy material; biochemical and serologic laboratories; a nutrition support service; and relevant social services. Close working relationships exist with other services including surgery, urology, obstetrics, gynecology, pediatrics and psychiatry. Harbor-UCLA Medical Center is a major Level 1 Trauma center for the southern Los Angeles County region. New Emergency Department and operating room facilities opened in April 2014.

(2) Center for the Health Sciences at UCLA. Fellows from the Harbor-UCLA Medical Center rotate

for one of their months of renal transplantation experience to this tertiary care facility. The Center for the Health Sciences is among the busiest renal transplant centers in the country. The hospital contains surgical and medical intensive care units, a dialysis unit that performs acute and chronic hemodialysis and supports continuous renal replacement therapies and peritoneal dialysis, radiologic services with modern renal-related procedures and diagnostic vascular and radionucleotide imaging, light, immunofluorescent and electron microscopies for renal biopsy material, biochemical and serologic laboratories, a nutrition support service, and relevant social services. A close working relationship exists with other services including surgery, urology and psychiatry.

B. Outpatient sites (1) DaVita Torrance Dialysis facility – Located diagonally across the street from the Harbor-UCLA

Medical Center, this 30-chair dialysis facility is the site for all outpatient hemodialysis and peritoneal dialysis training in the Harbor-UCLA educational program. Since the County of Los Angeles has no training site for chronic dialysis, an off-site location was developed. Fellows are assigned a shift of 25 dialysis patients and a dialysis mentor. These patients become the Fellow’s continuity patients throughout the fellowship. Rounding with the faculty mentor occurs twice a month. Fellows also attend an outpatient Peritoneal Dialysis clinic with faculty mentorship twice a month.

C. Off-campus sites

(1) DaVita Torrance Dialysis Facility – See (B) above (2) UCLA Center for the Health Sciences Transplantation rotation – See A (2) above

5) Nephrology Training Program Schedules

The two year clinical fellowship is comprised of four major rotations that cycle throughout the year: Consultation, Transplantation, Outpatient Nephrology, and Research/Elective. For the Outpatient Nephrology activity, fellows maintain activity in Outpatient Hypertension, General Continuing Care Nephrology, and Transplantation clinics, as well as Peritoneal dialysis and Hemodialysis rounding all year while they are primarily assigned to one of the other three major rotations. Therefore, although Outpatient Nephrology is delineated as a “rotation” in terms of a body of knowledge and experience,

fellows experience this “rotation” on a continuous basis during the entirety of the fellowship training program. A 2-week Elective is also part of the Curriculum. During this time, fellows are assigned a faculty mentor, and can elect to rotate on another service (for example, but not limited to Renal Pathology, Urology, Interventional Radiology, etc) or may use the time to perform their CQI project, do outside reading, or supplement their research time.

A. Yearly and daily schedules for fellows on clinical service (may be only 1 year for research fellows)

24 MONTH SCHEDULE: 2018/2019 FELLOW SCHEDULE

2017/2018 FELLOW SCHEDULE

JULY

AUGUST

SEPTEMBER

OCTOBER

NOVEMBER

DECEMBER

NEPHROLOGY/HYPERTENSION

CONSULTATION SERVICE

HOSPITAL DIALYSIS

Fellow A

Fellow B

Fellow F

Fellow G

Fellow A

Fellow C

Fellow D

Fellow G

Fellow F (16-30)

Fellow B

Fellow E

Fellow E (1-15)

Fellow D (16-31)

Fellow G

Fellow A

Fellow A (1-7)

Fellow C (8-30)

Fellow B (16-30)

Fellow F

Fellow E

Fellow B

Fellow D

Fellow F

ELECTIVE Fellow E (1-15)

HARBOR-UCLA A

TRANSPLANTATION

Fellow C Fellow E

Fellow G

Fellow F

Fellow D

Fellow A

HARBOR-UCLA B

TRANSPLANTATION

Fellow D

Fellow F

Fellow A

Fellow B (1-15)

Fellow E (16-31)

Fellow G

Fellow C

UCLA-CHS TRANSPLANTATION Fellow D

Fellow E

MFI/DAVITA

A. MORNING

B. MIDSHIFT

C. EVENING

MWF TThS

A D

B E

C F

MWF TThS

RS D

B E

C F

MWF TThS

RS D

B E

C F

MWF TThS

RS D

B E

C F

MWF TThS

RS D

B E

C F

MWF TThS

RS D

B E

C F

NEPHROLOGY CLINIC

All Fellows

All Fellows

All Fellows

All Fellows

All Fellows

All Fellows

TRANSPLANT CLINIC

All Fellows

All Fellows

All Fellows

All Fellows

All Fellows

All Fellows

HYPERTENSION CLINIC

All Fellows

All Fellows

All Fellows

All Fellows

All Fellows

All Fellows

RESEARCH

Fellow E (16-31)

Fellow B (1-15)

Fellow C (1-6)

Fellow D (1-15)

Fellow B (16-31)

Fellow B (1-15)

Fellow A (8-30)

VACATION Fellow F (22) ABIM

Fellow G (24) ABIM

Fellow B (16-31)

Fellow F (1-15)

Fellow C (7-30)

Fellow C (1-31)

MAT

Fellow C (1-7)

Fellow G (16-31)

INTERDISPLINPARY CARE PLAN AND QUALITY IMPROVEMENT: DIALYSIS FACULTY AND FELLOWS MONTHLY

HOSPITAL INTERDISPLINPARY ESRD CQI: ALL FACULTY AND FELLOWS QUARTERLY

2016/2017 FELLOW SCHEDULE

JANUARY

FEBRUARY

MARCH

APRIL

MAY

JUNE

NEPHROLOGY/HYPERTENSION

CONSULTATION SERVICE

HOSPITAL DIALYSIS

PGY4A

PGY5A

PGY4A

PGY4B

PGY4C

PGY4A

PGY4B

PGY4C

PGY4B

PGY4C

PGY4D

PGY4D

PGY4A

PGY5A

PGY4B

PGY4C

PGY4D

HARBOR-UCLA

TRANSPLANTATION

PGY4C PGY4D PGY5A PGY5A PGY4B PGY4A

UCLA-CHS TRANSPLANTATION PGY4B PGY4D PGY4C

MFI/DAVITA UNIT

A. MORNING

B. MIDSHIFT

C. EVENING

MWF TThS

PGY4D PGY4C

PGY5A PGY5A(R)

PGY4A PGY4B

MWF TThS

PGY4D PGY4C

PGY5A PGY5A(R)

PGY4A PGY4B

MWF TThS

PGY4D PGY4C

PGY5A PGY5A(R)

PGY4A PGY4B

MWF TThS

PGY4D PGY4C

PGY5A PGY5A(R)

PGY4A PGY4B

MWF TThS

PGY4D PGY4C

PGY5A PGY5A(R)

PGY4A PGY4B

MWF TThS

PGY4D PGY4C

PGY5A PGY5A(R)

PGY4A PGY4B

NEPHROLOGY CLINIC

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

TRANSPLANT CLINIC

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

HYPERTENSION CLINIC

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

PGY4A

PGY4B

PGY4C

PGY4D

PGY5A

RESEARCH

PGY4D

PGY5A(R)

PGY5A

PGY5A(R)

PGY5A(R) PGY4A

PGY5A(R)

PGY5A(R)

PGY5A

PGY5A(R)

WEEKLY CLINICAL SCHEDULE: DIVISION OF NEPHROLOGY WEEKLY SCHEDULED ACTIVITIES (Nephrology Core Curriculum for Residents and Students as per Separate Schedule)

DAY & TIME

ACTIVITY

LOCATION

PARTICIPANTS

MONDAY 12:30 - 1:30 1:30 - 2:00 2:00 – 3:00 3:00

UCLA-Wide Pathophysiology Course Fellows’Conference: PBLI, M&M, QOL, CQI Nephrology Grand Rounds Nephrology Consult Attending Rounds Transplant Attending Rounds

Parlow Library Parlow Library 5th Floor - Hospital

Fellows, Residents, Students Staff, Clinical and Research Fellows, Residents, Students, Attending Physicians Staff, Clinical and Research Fellows, Residents, Students, Attending Physicians

TUESDAY 8:30 - 9:30 All Day – Flexible- 2:00

Medical Grand Rounds Nephrology Consult Attending Rounds Transplant Attending Rounds

Peritoneal Dialysis clinic

Parlow Library 5th Floor - Hospital Torrance DaVita

Staff, Clinical and Research Fellows, Residents, Students Staff, Consult Fellows

Staff, Fellows

WEDNESDAY 8:00 - 1:00 3:30* 5:15 – 6:15

Transplant Clinic Nephrology Consult Attending Rounds Transplant Attending Rounds Nephrology Journal Club, Research presentations, or Renal

Pathology Conference+

POB/N28 5th Floor - Hospital C1-Annex

Staff, Clinical Fellows Staff, Consult Fellows, Residents, Students Staff, Clinical and Research Fellows, Residents, Students

THURSDAY 8:00 - 1:00 Start 3:30*

Nephrology Clinic Nephrology Consult Attending Rounds Transplant Attending Rounds

PCDC - Module A in Basement 5th Floor - Hospital

Staff, Clinical Fellows, Residents, Students Staff, Clinical and Research Fellows, Residents, Students, Attending Physicians

FRIDAY 10:30* 1:00 - 5:00 4:00 - 5:00

Nephrology Consult Attending Rounds with formal Weekend Check Out Transplant Attending Rounds Hypertension Clinic Transplant Rounds and Weekend Check Out

5th Floor - Hospital PCDC Module A 5th Floor Hospital

Staff, Consult Fellows, Residents, Students Staff, Clinical Fellows, Residents, Students Staff, Fellow on Call

* These starting times for Attending Rounds in transplantation or renal nephrology are approximate and will vary according to the specific schedule of the participants. + Renal Pathology Conference the first Wednesday of each month #PBLI: Practice Based Learning and Imrpovement conference; M&M: Moratlity and Morbidity conference; QOL: Question-Oriented Learning conference; CQI: Continuous QualityImprovement conference

THE UCLA TRANSPLANT ROTATION SCHEDULE:

Mon Tue Wed Thu Fri Sat/Sun/Holiday

6 a.m Pre Round Pre Round Pre Round Pre Round Pre Round

7

7:30 am Transplant conference (once/month) Donor selection meeting (remaining weeks)

8 Clinic Clinic Clinic Clinic Clinic

9 Peds.

10 Clinic In Patient

11 Rounds

12 noon Lunch Lunch Lunch Lunch Lunch

1 In Patient Round

In Patient Round

In Patient Round

In Patient Round In Patient Round

2

3 Eval. Clinic Eval. Clinic Selection Eval. Clinic Donor Eval

4 Meeting Clinic

5

6 p.m.

RESEARCH ROTATION SCHEDULE: At the start of the research rotation, fellows are expected to engage in an online course on ethics and laws regulating research, conflicts of interest, and HIPAA regulations, take on-line test, and obtain the certificates. Once certified, fellows meet with mentors to design the research project, review results, perform analyses, and draft abstracts, papers, and Nephrology Grand Rounds Powerpoint for presentation. Didactic online Research Curriculum modules with certifying tests are found at the LABiomed-sponsored site on Citi at https://www.citiprogram.org Fellows logon with LABiomed as the sponsoring institution, then get a username and password. There are 3 required modules: -Good Clinical Practices -Health Privacy -Conflict of interest Each module contains multiple submodules with online quizzes. Fellows are expected to complete each of the modules before starting their research, obtain a print or electronic certificate, and provide these to the Division of Nephrology when completed. Monday 8am - 12:30* Any of the following activities may take place: Meet with mentor, independent time for literature evaluation, didactic course work, study design, subject recruitment, subject follow-up, benchwork (if applicable), data analysis, regulatory reporting, Lab meetings, manuscript preparation 12:30 - 1:00 Lunch 12:30 - 1:30 UCLA-wide Pathophysiology course 1:30 - 300 Nephrology Grand Rounds 3:00 - 6:00 Any of the following activities may take place: Meet with mentor, independent time for literature evaluation, didactic course work, study design, subject recruitment, subject follow-up, bench work (if applicable), data analysis, regulatory reporting, Lab meetings, manuscript preparation Tuesday 8:30 - 9:30 am Medical Grand Rounds 9:30 - Noon Any of the following activities may take place: Meet with mentor, independent time for literature evaluation, didactic course work, study design, subject recruitment, subject follow-up, benchwork (if applicable), data analysis, regulatory reporting, Lab meetings, manuscript preparation Noon -1:00 pm Lunch at the Basic Science Conference 1:00 - 4:30 pm Two Tuesdays a month: Peritoneal Dialysis clinic

All other Tuesdays: Any of the following activities may take place: Meet with mentor, independent time for literature evaluation, didactic course work, study design, subject

recruitment, subject follow-up, benchwork (if applicable), data analysis, regulatory reporting, Lab meetings, manuscript preparation

Wednesday 8:00 - Noon Transplant clinic 1PM Lunch 2:00 – 5:15 pm Any of the following activities may take place: Meet with mentor, independent time for

literature evaluation, didactic course work, study design, subject recruitment, subject follow-up, benchwork (if applicable), data analysis, regulatory reporting, Lab meetings, manuscript preparation

5:15 – 6:15 pm Clinical/Basic Science journal club, Renal Pathology Conference, Research Conference Thursday 8:00 - 1:00 pm Nephrology clinic 1:00 - 1:30 pm Lunch 1:30 - 6:00 pm Any of the following activities may take place: Meet with mentor, independent time for

literature evaluation, didactic course work, study design, subject recruitment, subject follow-up, benchwork (if applicable), data analysis, regulatory reporting, Lab meetings, manuscript preparation

Friday 8:00 - 12:30 pm Any of the following activities may take place: Meet with mentor, independent time for

literature evaluation, didactic course work, study design, subject recruitment, subject follow-up, benchwork (if applicable), data analysis, regulatory reporting, Lab meetings, manuscript preparation

12:30 - 1:00 pm Lunch 1:00 - 5:00 pm Hypertension clinic 5:00 - 6:00 pm Any of the following activities may take place: Meet with mentor, independent time for

literature evaluation, didactic course work, study design, subject recruitment, subject follow-up, benchwork (if applicable), data analysis, regulatory reporting, Lab meetings, manuscript preparation

*A 3-hour block of time once per week is variably used for rounds in the chronic dialysis facility Total didactic and practical research protected hours per week: 26.5 hrs

6) Nephrology Clinical Training Program Curriculum – Overview A. Clinical Curriculum Introduction The Nephrology Fellowship Clinical Training Program is designed to provide individuals with the

opportunity to achieve the fundamental knowledge, procedural skills, practical experience, appreciation of continuous quality improvement and research procedures and skills, and professional and ethical behavior necessary for the subspecialty of Nephrology. Fellows care for patients with the full spectrum of renal disorders at all stages of the disease process. Efforts are made at every point to emphasize the integration of fundamental medical knowledge, disease prevention, continuous quality improvement, scholarship, social, psychological, and economic issues.

This section describes the clinical curriculum. The first part presents an outline of the Clinical

Program goals and objectives. Subsequently, the full clinical curriculum is described, relating Clinical Program goals and objectives to the manner in which they are achieved. A description of the evaluation process then follows.

B. Overview of Clinical Program Goals and Objectives The Nephrology Fellowship Clinical Training Program is structured around goals and objectives

derived from three major sources: 1) the ACGME Core Competencies and the requirements of the Next Accreditation System; 2) the ACGME subspecialty requirements for Nephrology training programs; and 3) additional input derived from Harbor-UCLA Medical Center Nephrology and Hypertension faculty. These various components are combined to achieve an integrated set of goals and objectives that cover all aspects of the training program.

In this first section, an overview of the training program’s goals and objectives is presented, broken

down by the six core competencies and then the specific Nephrology areas. This should be reviewed so that Fellows understand each of these components. The following section, devoted to the detailed curriculum, then combines the core competencies and specific nephrology issues into an integrated and comprehensive set of goals and objectives. The final section summarizes the Fellow performance evaluation process.

Overview of Supervision (adapted from ACGME): (1) Direct. The supervising physician is physically present with the fellow and patient (2) Indirect. The supervising physician may be present within the hospital or other site of patient care and is immediately available if direct supervision is needed. (3) Indirect supervision with direct supervision available. The supervising physician is not physically present within the hospital or other site of patient care, but is immediately available by phone and/or other means of direct electronic communication within 15 minutes of initial attempt of contact, and is available to provide direct supervision within 30 minutes in the event of an emergency. (4) Oversight. The supervising physician is available to provide review of procedures/encounters with feedback provided after the care is delivered. Core Competencies (1) Patient care – Fellows must be able to provide patient care in CKD, ESRD and AKI that is

compassionate, appropriate, and effective for the treatment of health problems and the promotion of health. Fellows are expected to:

Communicate effectively and demonstrate caring and respectful behaviors when interacting with patients with kidney disease and their families

Gather essential and accurate information about their patients

Make informed decisions about diagnostic and therapeutic interventions based on patient information and preferences, up-to-date scientific evidence, and clinical judgment

Develop and carry out patient management plans, including using CQI conferences for this purpose

Counsel and educate patients and their families about kidney diseases

Use information technology to support patient care decisions and patient education

Perform competently all medical and invasive procedures considered essential for the diagnosis and treatment of kidney diseases

Provide health care services aimed at preventing health problems or maintaining health

Work with health care professionals, including those from other disciplines, to provide patient-focused care, including nurses, dieticians, social workers, and technicians.

(2) Medical knowledge - Fellows must demonstrate knowledge about established and evolving

biomedical, clinical, and cognate (e.g. epidemiological and social-behavioral) sciences and the application of this knowledge to patient care. Fellows are expected to:

Demonstrate an investigatory and analytic thinking approach to clinical situations

Know and apply the basic and clinically supportive sciences which are appropriate to nephrology (3) Practice-based learning and improvement – Fellows must be able to investigate and evaluate their

patient care practices, appraise and assimilate scientific evidence, and improve their patient care practices. Fellows are expected to:

Analyze practice experience and perform practice-based improvement activities using a systematic methodology

Locate, appraise, and assimilate evidence from scientific studies related to their patients’ health problems

Obtain and use information about their own population of patients and the larger population from which their patients are drawn

Apply knowledge of study designs and statistical methods to the appraisal of clinical studies and other information on diagnostic and therapeutic effectiveness

Use information technology to manage information, access on-line medical information; and support their own education

Facilitate the learning of students and other health care professionals (4) Interpersonal and communication skills - Fellows must be able to demonstrate interpersonal and

communication skills that result in effective information exchange and teaming with patients, their patients families, and professional associates. Fellows are expected to:

Create and sustain a therapeutic and ethically sound relationship with patients

Use effective listening skills and elicit and provide information using effective nonverbal, explanatory, questioning, and writing skills

Work effectively with others as a member or leader of a health care team or other professional group (5) Professionalism - Fellows must demonstrate a commitment to carrying out professional

responsibilities, adherence to ethical principles, and sensitivity to a diverse patient population. Fellows are expected to demonstrate:

Respect, compassion, and integrity;

Responsiveness to the needs of patients and society that supersedes self-interest;

Accountability to patients, society, and the profession;

Commitment to excellence and on-going professional development;

Commitment to ethical principles pertaining to provision or withholding of clinical care, confidentiality of patient information, informed consent, and business practices; and

Sensitivity and responsiveness to patients’ culture, age, gender, and disabilities. (6) Systems-based practice - Fellows must demonstrate an awareness of and responsiveness to the

larger context and system of health care and the ability to effectively call on system resources to provide care that is of optimal value. Fellows are expected to:

Understand how their patient care and other professional practices affect other health care professionals, the health care organization, and the larger society and how these elements of the system affect their own practice

Know how types of medical practice and delivery systems differ from one another, including methods of controlling health care costs and allocating resources

Practice cost-effective health care and resource allocation that does not compromise quality of care

Advocate for quality patient care and assist patients in dealing with system complexities

Know how to partner with health care managers and health care providers to assess, coordinate, and improve health care and know how these activities can affect system performance.

The 23 reportable milestones. Twenty-three behaviors/experiences have been identified that are designated reportable ACGME milestones. All Fellows will be evaluated quarterly in the context of achieving these milestones. The Training Program Director will meet quarterly with fellows to review these, two of which will also be reviewed by the Clinical Evaluation Committee (at 6-month intervals). The tools will be used to measure a fellow’s training trajectory and will evaluate growth in the achievement of the milestones. The 23 behaviors/experiences are:

1. Gathers and synthesizes essential and accurate information to define each patient’s clinical problem(s).

2. Develops and achieves comprehensive management plan for each patient. 3. Manages patients with progressive responsibility and independence. 4a. Demonstrates skill in performing and interpreting invasive procedures. 4b. Demonstrates skill in performing and interpreting non-invasive procedures and/or testing. 5. Requests and provides consultative care. 6. Possesses Clinical knowledge. 7. Knowledge of diagnostic testing and procedures. 8. Scholarship. 9. Works effectively within and interprofessional team (e.g., with peers, consultants, nursing, ancillary

professionals, and other support personnel). 10. Recognizes system error and advocates for system improvement. 11. Identifies forces that impact the cost of health care, and advocates for and practices cost-effective

care. 12. Transitions patients effectively within and across health delivery system. 13. Monitors practice with a goal for improvement. 14. Learns and improves via performance audit. 15. Learns and improves via feedback. 16. Learns and improves at the point of care. 17. Has professional and respectful interactions with patients, caregivers, and members of the

interprofessional team (e.g., peers, consultants, nursing, ancillary professionals, and support personnel).

18. Accepts responsibility and follows through on tasks. 19. Responds to each patient’s unique characteristics and needs. 20. Exhibits integrity and ethical behavior in professional conduct. 21. Communicates effectively with patients and caregivers. 22. Communicates effectively in interprofessional teams (e.g., with peers, consultants, nursing,

ancillary professionals, and other support personnel).

23. Appropriate utilization and completion of health records. Specific Renal Competencies - Fellows will acquire expertise in: (1) An understanding of normal renal biology including: a. Renal anatomy and histology b. Renal physiology, including in the elderly c. Fluid, electrolyte and acid-base regulation d. Mineral metabolism e. Blood pressure regulation - normal and abnormal f. Renal drug metabolism and pharmacokinetics, including drug effects on renal function and

including in the elderly g. Renal function in pregnancy h. Basic immunologic principles, including mechanisms of disease and diagnostic laboratory

testing relevant to renal diseases i. Medical genetics (2) Prevention, evaluation, and management of general nephrologic disorders including: a. Acute kidney injury b. Chronic kidney disease c. End-stage renal disease d. Fluid, electrolyte, and acid-base disorders e. Disorders of mineral metabolism including nephrolithiasis and renal osteodystrophy (including

use of lithotripsy) f. Urinary tract infections g. Hypertensive disorders h. Renal disorders related to pregnancy i. Primary and secondary glomerulopathies including infection-related glomerulopathies. This

also entails a basic understanding of immunologic mechanisms of renal disease and the laboratory tests necessary for their diagnosis.

j. Diabetic kidney disease k. Tubulointerstitial nephritis including papillary necrosis l. Genetic and developmental renal diseases including renal cystic diseases, hereditary

glomerulopathies and interstitial nephritis, phakomatoses, systemic diseases with renal involvement, congenital malformations of the urinary tract, maternally inherited mitochondrial diseases, and renal cell carcinoma.

m. Vascular diseases including atheroembolic disease n. Disorders of drug metabolism and renal drug toxicity o. Renal disorders associated with the elderly including altered drug metabolism p. Renal cystic diseases without a recognized genetic basis q. Nutritional management of general nephrologic disorders r. Renal disorders in pregnancy (3) Pre- and post-renal transplant care including: a. Pre-transplant selection, evaluation and preparation of transplant recipients and donors b. Immunosuppressant drug effects and toxicity c. Immediate postoperative management of transplant recipients d. Immunologic principals of types and mechanisms of renal allograft rejection e. Clinical diagnosis of all forms of rejection including laboratory, histopathologic and imaging

techniques f. Prophylaxis and treatment of allograft rejection

g. Recognition and medical management of nonrejection causes of allograft dysfunction including urinary tract infections, acute renal failure, and others

h. Understanding major causes of post-transplant morbidity and mortality i. Fluid, electrolyte, mineral and acid-base regulation in post-transplant patients j. Long-term follow-up of transplant recipients in the ambulatory setting including economic and psychosocial issues k. Principles of organ harvesting, preservation and sharing l. Renal disease in liver, heart and bone marrow transplant recipients (4) Dialysis and extracorporeal therapy including: a. Evaluation and selection of patients for acute hemodialysis or continuous renal replacement

therapies b. Evaluation of end-stage renal disease patients for various forms of therapy and their instruction regarding treatment options c. Drug dosage modification during dialysis and other extra-corporeal therapies d. Evaluation and management of medical complications in patients during and between dialyses

and other extra-corporeal therapies, and an understanding of their pathogenesis and prevention

e. Long-term follow-up of patients undergoing chronic dialysis including their dialysis prescription modification and assessment of adequacy of dialysis

f. An understanding of the principles and practice of peritoneal dialysis including the establishment of peritoneal access, the principles of dialysis catheters, and how to choose appropriate catheters

g. An understanding of the technology of peritoneal dialysis including the use of cyclers h. Assessment of peritoneal dialysis efficiency using peritoneal equilibration testing and the

principles of peritoneal biopsy i. An understanding of how to write a peritoneal dialysis prescription and how to assess

peritoneal dialysis adequacy j. The pharmacology of commonly used medications and their kinetic and dosage alteration with

peritoneal dialysis k. An understanding of the complications of peritoneal dialysis including peritonitis and its

treatment, exit site and tunnel infections and their management, hernias, pleural effusions and other less common complications and their management

l. An understanding of the special nutritional requirements of the hemodialysis and peritoneal dialysis patient

m. An understanding of the psychosocial, economic and ethical issues of dialysis n. An understanding of dialysis water treatment, delivery systems and dialyzer reuse o. An understanding of end-of-life care and pain management in the care of patients undergoing

chronic dialysis. (5) Personally conducting the following procedures: a. Urinalysis b. Percutaneous biopsy of native and transplanted kidneys c. Peritoneal dialysis prescription d. Placement of temporary vascular access for hemodialysis and/or CRRT, including the use of

vascular ultrasound guidance e. Acute and chronic hemodialysis prescriptions f. Continuous renal replacement therapies prescription (6) Understanding indications, complications (if relevant), and interpretation of the following procedures:

a. Placement of peritoneal catheters b. Renal imaging - ultrasound, CT, IVP, MRI, angiography, and nuclear medicine studies c. Therapeutic plasmapheresis d. Radiology, angioplasty and declotting of vascular access (7) Special areas in the management of patients with renal disease, including: a. Psychosocial and economic issues confronting patients with renal disease b. Ethical issues relevant to the care of patients with renal disease c. Optimizing the relationship of the nephrologist with other health care providers d. Optimizing mechanisms towards achieving life-long learning as a nephrologist e. Quality assessment and improvement, patient safety, risk management, preventative

medicine, and physician impairment as it relates to the nephrologist f. Psychosocial and medical issues pertaining to the transition of the pediatric and/or adolescent

renal patient to adulthood (8) Transitions of Care. Transition of care is an integral part of the training experience. The Transitions of

Care policy for the Division of Nephrology and Hypertension is identical to the policy outlined for all areas of care at Harbor-UCLA Medical Center, as documented below.

The Accreditation Council for Graduate Medical Education (ACGME) requires that Sponsoring Institutions and residency/fellowship programs ensure and monitor effective structured handoff processes to facilitate both continuity of care and patient safety. Ensuring effective transitions of care is an essential component of learners’ achieving proficiency in patient care, interpersonal and communication skills, systems-based practice, and professionalism. Handovers occur upon admission, at shift changes, upon unit changes, and at discharge. Handovers within the healthcare system are high-risk, high-frequency events in which critical information about a patient’s clinical status, including current condition and recent and anticipated treatment, must be transferred completely and accurately to ensure safe and effective continuity of care.

Purpose: To establish a protocol and standards within the Harbor-UCLA Medical Center Graduate Medical Training programs (residency and fellowship) to ensure the quality and safety of patient care when transfer of responsibility occurs during duty hour shift changes, during transfer of the patient from one level of acuity to another, and during other scheduled or unexpected care transitions.

Definition: A transition of care (“handover”) is defined as the communication of information to support the transfer of care and responsibility for a patient/group of patients from one service and/or team to another. The transition/hand-over process is an interactive communication process of passing specific, essential patient information from one caregiver to another.

Policy Statement: A “handover” is a verbal and/or written communication which provides information to facilitate continuity of care. Handovers should follow a standardized protocol and include the opportunity to ask and respond to clinical questions.

General Principles:

1. Individual programs must have a policy addressing transitions of care. Faculty and trainees must be aware of their program policy.

2. Individual programs should provide instruction of Departmental processes with trainees regarding handover of care.

3. Individual programs must design schedules and clinical assignments to maximize the learning experience for residents as well as to ensure quality care and patient safety, and adhere to general institutional policies concerning patient safety and quality of healthcare delivery.

4. Individual programs should evaluate trainees in their capacity to perform a safe, effective, and accurate handover of care.

Procedure: The following procedures apply to all care providers who are teachers or learners in a clinical environment and have responsibility for patient care in that environment.

1. Handover procedures will be conducted in conjunction with (but not be limited to) the following events:

a. Shift Changes b. Change in level of patient care, including inpatient admission from the ambulatory setting,

outpatient procedure, or diagnostic area. c. Inpatient admission from the Emergency Department d. Transfer of a patient to or from a critical care unit e. Transfer of a patient from the Post Anesthesia Care Unit (PACU) to an inpatient unit when

a different physician will be caring for that patient f. Transfer of care to other healthcare professionals within procedure or diagnostic areas g. Discharge, including discharge to home or another facility such as skilled nursing care h. Change in provider or service change, including resident sign-out, inpatient consultation

sign-out, and rotation changes for residents.

2. The transition process includes, at a minimum, the following information in a standardized format. SBAR format (Situation, Background, Assessment, Recommendations) is an example of one such format. The policy and the approach to hand-overs should be based on the patient care setting and the role of the trainee (e.g. consultant, primary team, team leader) in patient care activities.

3. The fellowship program of the Division of Nephrology and Hypertension developed a transition of care policy that integrates specifics from our specialty field. We developed scheduling and transition/hand-over procedures to ensure that:

a. Fellows comply with specialty specific/institutional duty hour requirements. Our current on-call obligations are consistent with the duty hour limits. We have a back-up fellow on the schedule in the event that the workload exceeds the limits. Fellows report their duty hours, and these are reviewed by the Training Program Director and the Clinical Competency Committee.

b. Faculty are scheduled and available for appropriate supervision levels according to the requirements for the scheduled residents.

c. All parties (including nursing) involved in a particular program and/or transition process have access to one another’s schedules and contact information. All call schedules are available on department-specific password-protected websites and also with the hospital operators.

d. All parties directly involved in the patient’s care before, during, and after the transition have the opportunity for communication, consultation, and clarification of information. Formal hand-off rounds occur on Fridays on the consultation team with the entire team, including the fellows, residents, nurse practitioners, residents, students, and the attending.

e. Feedback about handover skills is part of the 23-milestone evaluation process.

4. Nephrology provides specific training and education on the Transition of Care Process. Methods of training to meet this requirement may include lecture-based hand-over education (provided during hospital-wide orientation), web-based or self-directed hand over tutorials, specialty specific orientation sessions, didactics, workshops, interactive teaching tools, or simulation.

5. Fellows must demonstrate competency in performance of handover. The following describes the

mechanisms through which the program may elect to determine the competency of trainees in handoff skills and communication:

a. Direct observation of a handover session by faculty b. Evaluation of handover materials available on the Physician Handoff EMR portal c. Assessment of handoff quality in terms of ability to predict overnight events d. Assessment of adverse events and relationship to sign-out quality through rounding

review

6. The fellows in the Division of Nephrology and Hypertension participate in the same required didactic training administered by the GME office at Harbor-UCLA Medical Center as all of the other training programs. The Nephrology faculty on the consultation and the transplantation teams directly oversee the actual transition of care in preparation for weekend coverage. The members of the Division of Nephrology and Hypertension have a Clinical Evaluation Committee whose members evaluate the performance of each fellow and who can update and/or modify the handoff process as necessary. Monitoring of handovers by the program ensures:

a. There is a standardized process in place that is routinely followed b. There are consistent opportunities for questions c. The necessary materials are available to support the handover (including access to

written or electronic clinical information) d. A quiet setting free of interruptions for handover processes that can include face-to-face

communication e. Patient confidentiality and privacy are ensured in accordance with HIPAA guidelines; this

includes the appropriate disposal of any written material in HIPAA-compliant receptacles, and encryption of any electronic devices used during the handoff process.

7. Fellowship handoff agreement for academic year July 1, 2018-June 30, 2019 a. Fellows who are on the short-call and long-call schedule for Saturdays are

responsible for creating a collated handover list for the Friday 8PM covering physician to be emailed by the HIPPA-secure County email system.

8. Essential elements of this handover communication minimally include:

a. Identification of patient, including name, medical record number, and location b. Diagnosis and current status/condition (level of acuity including code status) of patient c. Recent events, including changes in condition or treatment, anticipated procedures and

actions to be taken d. Outstanding tasks: what needs to be completed in immediate future e. Outstanding laboratories/studies: what needs follow up during shift f. Changes in patient condition that may occur requiring interventions or contingency

plans 9.

i. Short-call fellow will create the ICU/Transplant list ii. Long-call fellow will create the remainder of the list iii. These lists will be emailed:

1. Friday evening to the covering attending 2. Saturday morning from the covering attending to the short and long-

call fellow and the supervising Consult attending 3. Sunday morning to the Sunday covering attending physician 4. Monday morning from the Sunday covering attending physician to the

short and long-call fellow and the supervising Consult attendings 5. Short and long-call fellows will redistribute information and new

patients to Consult and Transplant fellows on Monday morning 6. Verbal communications may be helpful for critically ill patients with

rapidly changing clinical status, and also for more stable patients for whom special instructions would facilitate patient care

iv. All fellows and NPs are expected to maintain all of the patients in the Physician Handoff area of Orchid. Instructions to enter and remove patients are below:

How To Make and Maintain an ORCHID Care Team List for the Physician Handoff Process:

Creating your list

1. Open Orchid and click Physician handoff

7. The Nephrology and Hypertension program evaluates trainees on their ability to communicate patient information clearly, accurately, and responsibly to support the safe transfer of care from one provider to another. 8. The Nephrology and Hypertension TPD has specific responsibilities regarding hand-offs. The TPD:

• Establishes the process for, and monitors the performance of, handover procedures • Ensures that each fellow is competent in handovers and provides the information needed for timely, accurate, complete and effective handoffs • Creates assignments to minimize the number of transitions of patient care • Provides written documentation of the program’s handover policy including evidence of effective implementation as part of the Annual Program Review.

a. The transferring resident/fellow must:

i. Comply with handover policy and procedures ii. Respond to questions and resolve discrepancies and concerns in a timely manner iii. A fellow must not leave the hospital until a handover has occurred with the fellow/NP/PA/Attending that is assuming care of the patient.

b. The receiving fellow must:

i. Review a written or electronic handover form or receive a direct verbal handover, either in person, by phone, or by other secure and confidential electronic means of communication.

ii. When appropriate, document in the electronic health record the information pertinent to the continuing care of the patient. Instances requiring EHR documentation would include: (but not limited to): transfers to a new team of providers or to another hospital unit; transfers between the hospital and other care facilities; discharges to home; and patients who are unstable or will require significant diagnostic testing or interventions.

iii. Resolve any questions with the transferring attending, resident/fellow, or NP/PA prior to acceptance of a patient.

9. The GME Committee:

a. Ensures and monitors structured handover processes and makes appropriate recommendations in order to continuously improve patient safety and quality of care; and b. Assures compliance through summary reporting as part of the Annual Program Review for each program. c. The GMEC will also receive informal or formal feedback from the Patient Safety Officer member of the GMEC regarding the impact and effectiveness of the transition of care process on patient safety.

Progressive objectives The objectives of the Nephrology fellowship program are designed to reflect a progressive increase in learning and independence. The learning principles are based on Bloom's taxonomy, describing progression through the six learning domains: knowledge, comprehension, application, analysis, synthesis and evaluation. In practice, the program's objectives change at the completion of the first year of the 2-year training period. The progressive change in objectives are summarized in the sections addressing the four major rotations: Consultation, Transplantation, Research/Elective, and Outpatient Nephrology.

Months 1-12. Fellows function at least at the level of accurate reporting of the history, physical examination, and other data, i.e., they correctly recall and state the relevant facts. Fellows begin to understand or comprehend this information, reviewing and reporting the relevant facts in an organized and efficient manner. Fellows begin to describe how to apply this information to make

diagnostic and therapeutic decision. With more experience, Fellows are able to accurately interpret the history, physical examination, and data. The information is analyzed and an accurate differential diagnosis is formulated. Fellows continue in their abilities to design a diagnostic plan and therapeutic interventions.

Months 13-21. Fellows are able to correctly manage patient care. This extends previous

expectations to formulating a correct diagnostic plan, making the correct diagnosis. They should be beginning to critically analyze literature relevant to the care issues.

Month 22-24. Fellows are competent in all six core competencies and have achieved competency in the 23 Milestones. They function as self-educators, reading and analyzing the literature, and adjust their care based on this analysis. They also function as educators in a larger context, using their clinical experience and information they have obtained from the literature to teach their patients, colleagues, staff, and faculty.

These progressive objectives are provided to the fellows at the start of training and reviewed by the Program Director at the beginning of the second 12 months of training. Major areas in which a graduated level of function are anticipated in year 2 include:

Consultation

An anticipation that fellows will be more independent in the handling of patients with routine clinical presentations and in line placement

Greater responsibility for teaching residents and medical students on the Nephrology Consultation service, including participating in the Core Curriculum lecture series for residents and greater oversight of resident cases on service

Conjoint responsibility with faculty in instructing and certifying first year fellows in internal jugular and femoral vein catheterization

Greater independence in deciding which cases to present in detail to the on-call attending at night and over weekends

Transplantation More independence in the evaluation of transplant recipients and donors

Research/CQI

Requirement for delivering a CQI conference, Mortality & Morbidity Conference, and a Nephrology Grand Rounds on the chosen research topic by the end of Year 2 of fellowship training

Aspirational expectation to submit for publication an abstract or paper covering the work 7. Full Clinical Curriculum - in this section, specific Clinical Program goals and objectives, as outlined

above, are related to the methods by which they are achieved. The methods of achieving the Clinical Program goals include:

Types and locations of clinical encounters

Patient characteristics including case-mix, population size, sex, age, and race

Relevant procedural training

Relevant educational training, including resources and teaching methods

Nature of supervision

Means of feedback and evaluation of Fellow’s performance A. Renal structure and function - Fellows will acquire expertise in understanding normal renal

biology including renal anatomy and histology, renal physiology, fluid and electrolyte regulation, acid-base balance, mineral metabolism, blood pressure regulation, renal drug metabolism and pharmacokinetics, drug effects on renal function, renal function in pregnancy, renal functional changes with aging, and basic immunologic principles.

1) Educational training a. Literature availability - At the beginning of the fellowship, fellows are provided with

associate membership to the American Society of Nephrology the National Kidney Foundation, and the Renal Physicians Association, providing them with their own subscriptions to JASN, NephSap, CJASN and AJKD journals. Fellows are also given access to UpToDate on the hospital computer system. Hundreds of additional journals and thousands of textbooks are available at the Parlow Library adjacent to the hospital, and is open Monday through Friday from 8:00 am to 7:30 pm. Fellows are also encouraged to access PubMed,Google Scholar, and Google Images.

b. Didactic sessions - While normal renal biology is discussed during more informal

sessions (attending rounds, renal clinics) it is recognized that a structured approach is necessary to guarantee coverage of the basics of normal renal biology and pathology. The following didactic lecture and conference series covers the full range of Nephrology education as they relate to the four core rotations, Consultation, Transplantation, Research, and Outpatient clinics.

i. Introductory General Nephrology Course. At the beginning of the Fellowship, a

6-week course is given to provide trainees with a basic level of instruction regarding several issues in Nephrology key to becoming a new renal fellow. While it is geared primarily towards a basic level of instruction regarding topics in Nephrology that the fellow is unlikely to have covered during residency and will need to understand immediately at the outset of their fellowship (mechanics of dialysis and transplant protocols), some general nephrology issues are also discussed. The course continues over the six weeks of the fellowship, and is comprised of approximately 20 lectures and practicums. Fellows are provided a flashdrive with the Powerpoint presentations.

ii. Introductory Renal pathology course. Held for 3 hours during the first few weeks

of the beginning of the fellowship, an introductory course is provided by the Renal Pathologists covering technical issues of fixation and staining and the interpretation of renal biopsy material by light, immunofluorescent, and electron microscopies.

iii. Pathophysiology conference is held each Monday from 12:30 – 1:30 PM. This

conference is given by the faculty of all of the UCLA-affiliated training programs, including Harbor-UCLA Medical Center, the David Geffen School of Medicine at UCLA, the West Los Angeles VA Medical Center, Olive View Medical Center, and Cedars-Sinai Medical Center, and is attended by all of the first-year fellows in these programs. A yearly schedule is provided and two inservice examinations are given at the end of the year. At least a one-hour session is devoted to each of the following normal renal biology topics: water handling, potassium balance, sodium and volume, acid-base balance, Ca/Mg/PO4 metabolism, renal immunology, blood pressure regulation, and renal function in pregnancy. Drug metabolism is discussed during several sessions dealing with antihypertensives, immunosuppressants, and other topics. Renal anatomy and histology are extensively discussed during several sessions on glomerular and interstitial diseases

in which diseased kidneys are compared to normal kidneys. Mechanics of peritoneal and hemodialysis are discussed, as are topics in the evaluation and management of transplant recipients and donors. Nature of supervision: Faculty members facilitate discussion of the material during the didactic sessions. Means of Fellow evaluation – Fellows are encouraged to participate actively in learning through question and answer interchange and receive immediate feedback on their knowledge base during the didactic sessions. Two locally administered inservice examinations are given on the information provided during the year-long course.

iv. Renal pathology conference is held one Wednesday a month from 5:15 to 6:15 PM

covering 3-4 patients who recently had renal biopsies performed by the fellows. Fellows present the clinical data and the light, immunofluorescent and electron microscopy images are presented by the Renal Pathologist. A discussion of the clinical course, plans and follow-up are discussed for each case. Nature of supervision: Faculty members (Nephrology and Renal Pathology) facilitate discussion of the material during the didactic sessions. Means of Fellow evaluation – Fellows are encouraged to interpret the images presented and receive immediate feedback regarding their interpretations.

v. Nephrology Grand Rounds are held each Monday from 1:30 to 3:00 PM. During the

first half hour fellows make presentations according to particular structures: Practice based learning and improvement; Mortality and Morbidity; Continuous Quality Improvement; and Question-Oriented Learning. Faculty are also assigned on occasion to participate in Question-Oriented Learning sessions.

During the subsequent hour, a faculty member or invited speaker covers an area of relevance in nephrology as a didactic lecture or as a case-based discussion. Nature of supervision: Faculty members give the didactic lecture and/or facilitate discussion of the material during the didactic sessions. Means of Fellow evaluation – Fellows are encouraged to participate actively in learning through question and answer interchange and receive immediate feedback on their knowledge base during the didactic sessions. Both fellows and faculty submit formal evaluations of these conferences.

Practice-based Learning and Improvement conference is held as the first half hour of

Monday Nephrology Grand Rounds. Fellows may present one of two types of presentation. 1. Fellows may pose a specific question stimulated by a patient-based therapeutic or diagnostic problem presented in a pre-test form, discuss the answer to this question based on a review of the literature and/or other sources, define the sources used to answer the question, and then pose a post-test question for answer by the audience. 2. Alternatively, Fellows may use this conference to present the results of their personal System-based Practice (Continuous Quality Improvement) study or Mortality and Morbidity presentation. Each fellow is required to carry out one Continuous Quality Improvement project and one Mortality and Morbidity conference. Nature of supervision: Faculty members facilitate discussion of the material during the didactic sessions. Means of Fellow evaluation – Fellows are encouraged to participate actively in learning through question and answer interchange and receive immediate feedback on their knowledge base during the didactic sessions. A post-test question(s) is included in the structure of this didactic exercise to measure the success of the learning experience. Both fellows and faculty submit formal evaluations of these conferences.

vii. Ultrasonography Simulation Laboratory. Fellows receive a practicum comprised of

hands-on simulation experience in renal and vascular ultrasonography. Nature of supervision: Faculty members are present at the simulation lab to teach renal biopsy and temporary dialysis catheter placement techniques. Means of Fellow evaluation – Fellows

participate actively in learning through question and answer interchange, interpretation of ultrasound images, and through hands-on use of the ultrasound machine in simulation. They receive immediate feedback on their skills in using ultrasonography for these invasive procedures during these didactic sessions. A Mini-CEX is performed during this simulation experience.

viii. Clinical and Basic Science Journal Club is held on Wednesdays from 5:15 to 5:45

PM. All faculty and fellows rotate on a weekly basis as the presenter. The paper is chosen by the presenter and may be a paper from the recent medical literature, a landmark paper, a NephSap issue, or a recent set of guidelines. It is the responsibility of the presenter to review the clinical problem addressed as well as the design, implementation, results, and statistical analysis, and critique the overall validity of the conclusions drawn. Over the 2 year period,, the broad range of Nephrology basic science and clinical topics are covered including general nephrology and transplantation, ethical issues, normal physiology in health and pregnancy, issues relating to care of the aged, and special pharmacology concerns in patients with CKD and ESRD. Robust audience participation in the discussion is encouraged, expected, and accomplished! Nature of supervision: Faculty members facilitate discussion of the material during the didactic sessions. Means of Fellow evaluation – Evaluation forms are distributed at the start of the journal club for the formal evaluation of this activity.

ix. Comprehensive Advanced Dialysis Course is held every other year, so that each

PGY4 and PGY5 fellow participates once in the course during his/her training. The course is given on approximately one Friday morning per month for approximately 20 weeks. It includes lectures on peritoneal and hemodialysis urea kinetics, vascular and peritoneal dialysis access, nutrition in ESRD, management of anemia and metabolic bone disease, and general medical care of the ESRD patient. The full curriculum can be viewed on the Divisional Website Fellow Educational Corner. Nature of supervision: Faculty members facilitate discussion of the material during the didactic sessions. Means of Fellow evaluation – Fellows are encouraged to participate actively in learning through question and answer interchange and receive immediate feedback on their knowledge base during the didactic sessions.

x. Transplant-Infectious Disease Combined conference is held every 2 months. A

recent case of a renal transplant patient with an infectious complication is presented and discussed by the Renal and Infectious disease fellows with active audience participation by the fellows and faculty of both Divisions. Nature of supervision: Faculty members facilitate discussion of the material during the didactic sessions. Means of Fellow evaluation – The renal fellow presents the case and provides some clinical context for the ID discussion to follow. Fellows are encouraged to participate actively in learning through question and answer interchange and receive immediate feedback on their knowledge base during the didactic sessions.

xi. Medical Grand Rounds is held each Tuesday from 8:30 to 9:30 PM. A faculty

member or invited speaker covers an area of relevance in Internal Medicine as a didactic lecture or as a case-based discussion. Nature of supervision: Faculty members give the didactic lecture and/or facilitate discussion of the material during the didactic sessions. Means of Fellow evaluation – Fellows are encouraged to attend and participate actively.

x. Research conference is held one Wednesday per month in place of a basic science

journal club paper. Faculty or fellows may present original research. Nature of supervision: Faculty members facilitate discussion of the material during the sessions. Means of Fellow evaluation – Fellows attend and are encouraged to participate actively.

2) Means of Fellow evaluation – In addition to the fellow evaluations accompanying each of the

didactic and clinical activities of fellow trainees, comprehensive quarterly formal evaluations are provided during which the Training Program Director counsels fellows on areas of weakness and strength. The evaluation process conforms with the requirements of the Next Accreditation System and is described in detail later in this document.

B. General Consultative Nephrology 1) Goal: Progressive responsibility

Fellows will become competent in caring for patients with general nephrology problems and advance through stages of progressive responsibiolity to independence.

2) Objectives Detailed objectives for each rotation are described. A rotation is defined as a defined period (2-4

weeks) on one of the four Core Rotations – Consultation, Transplantation, Research/Elective, and Outpatient Nephrology. There are separate objectives for these four rotations during Years 1 and 2. These objectives reflect a progressive increase in expectations for fellows' competency achievement. The essence of the objectives for each rotation are as follows:

Months 1-12. Fellows progress from initially reporting the history, physical examination and other

data, to understanding and comprehending this information, organizing, reviewing and reporting the relevant facts efficiently, and finally to synthesizing the information, considering all of the diagnostic and therapeutic options, and focusing in on the best recommendations. Fellows learn to perform urinalysis accurately and progress from direct monitoring of line placement to independent line placement.

Months 13-21. Fellows are expected to make increasingly more independent diagnostic and

therapeutic decisions, and hone their ability to design diagnostic plans and therapeutic interventions in an increasingly sophisticated and thoughtful manner. Fellows are expected to take on greater responsibility for teaching residents and medical students on the Nephrology Consultation service, including participating in the Core Curriculum lecture series for residents and providing greater oversight of resident cases on service. Fellows are expected to develop conjoint responsibility with faculty and other certified personnel in instructing and certifying first year fellows in internal jugular and femoral vein catheterization. While in Year 1, fellows are expected to present all the patients seen over the weekend to the faculty attending; during Year 2 fellows will be permitted greater independence consistent with clinical maturity in deciding which follow-up cases to present in detail to the on-call attending over weekends and the degree of detail necessary to present new consults.

Month 22-24. Fellows should be competent in all six core competencies and have achieved

satisfactory levels of function for the 23 reportable milestones. They function as self-educators, reading and analyzing the literature, and adjusting their care based on this analysis. They also function as educators in a larger context, using their clinical experience and the information they have obtained from the literature to teach their juniors, colleagues, staff, nurse practitioners, and faculty.

3) Types of clinical encounters and supervision Consultation encounters. Fellows spend approximately 8 months/year on the inpatient

consultation service. Fellows receive consultation requests from the primary care teams of Surgery, Obstetrics-Gynecology, Family Practice, Internal Medicine, Cardiology, Adolescent

Medicine, and Psychiatry. The Fellow is the first person from the Nephrology Service to evaluate a new inpatient, including a history, physical examination, and urinalysis (the latter faculty-supervised, especially in the first few months). The Fellow follows all nephrology inpatients with daily history and examinations and, after discussion with faculty, and charts recommendations. Supervision: The fellow performs all consultations and writes all dialysis orders under the supervision of the Attending Nephrologist. During early fellowship, these are performed under direct supervision, and with progressive expertise and experience of the fellow, this is advanced to indirect supervision. The Attending conducts didactic sessions each day on material relevant to the in-house cases in concert with the clinical reviews of the patients. The Fellow arranges for outpatient renal follow-up to ensure continuity of care. Consultation requests after hours are always presented to an on-call faculty member, who provides indirect supervision with direct supervision availability. An Attending is on-call with the Fellow 24 hours a day. On Fridays, formal supervised rounds with the Attending includes plans for weekend handovers.

C. Outpatient Nephrology experience: a. General Nephrology Continuity Clinic. Each Thursday morning from 8:00 AM – 1:00 PM, all

Fellows, regardless of rotation, attend the general nephrology continuity clinic covering all aspects of nephrology except transplantation and dialysis. Patients are assigned to Fellows and followed on a continuity basis throughout their clinical fellowship. Drs. Adler, Dai, and Tong staff the clinic with occasional back-up (for emergencies, vacation, academic enrichment, or illness) by Dr. Shen. Supervision: Each patient is presented to the attending who is in the clinic to supervise and teach. Every patient seen in the clinic is presented to faculty. Each fellow sees approximately 6-8 patients during a 5-hour session. Supervision may be direct or indirect depending on the complexity of the problem and the skills of the fellow.

b. Hypertension Clinic. Each Friday afternoon from 1:00-5:00 PM all fellows, regardless of the other

rotational assignments, attend the Hypertension clinic, which specializes in the care and management of refractory cases of hypertension, as well as the diagnosis and management of secondary forms of hypertension. It also serves as the clinic for the care of patients with renal stones and cystic renal disease. The clinic is staffed by Dr Shah with back-up from Drs. Chan, Dukkipati, and Sawelson (for emergencies, vacation, academic enrichment, or illness). Supervision: Each patient is presented to the attending who is in the clinic to provide direct and/or indirect supervision and to teach. Each Fellow is given a minimum of 1/2 hour for follow-up visits and 1 hour for new patients. Each fellow sees approximately 4-6 patients during a 4-hour session. Supervision may be direct or indirect depending on the complexity of the problem and the skills of the fellow.

c. Peritoneal Dialysis Clinic. Two Tuesday afternoons a month Fellows attend the Peritoneal

dialysis clinic providing a monthly evaluation to peritoneal dialysis patients. Drs. Shah, Adler, and Tong staff the clinic with back-up (for emergencies, vacation, academic enrichment, or illness) by Drs. Dai, Shen, and Dukkipati. Supervision: The faculty supervises and trains the Fellows. Fellows also have the opportunity to interact with and learn from the Peritoneal Dialysis nursing staff. Every patient seen in the clinic is presented to and seen by faculty, who provide direct supervision. Each fellow sees approximately 3-5 patients per clinic.

d. Chronic hemodialysis (DaVita facility). Each fellow is assigned a faculty mentor and a shift of 25 patients as a continuity cohort for which he/she is responsible over the 2 years of fellowship. Fellows round twice monthly with the attending directly supervising each month, and rounds twice monthly separately. Each set of rounds takes approximately 3 – 3 ½ hours. This is an important part of the fellows’ ESRD education, where they experience the care of ESRD patients longitudinally, and they learn the responsibility of the nephrologist for these patients from the clinic,

to the dialysis facility, to transplantation, and unfortunately, in some cases, to death. Fellows learn strategies to enhance patient satisfaction, and to enhance patient outcomes. Fellows review their clinical outcomes monthly in interdisciplinary CarePlan meetings with nurses, social workers and dieticians. Patients, nurses, social workers, and dieticians yearly in 360o evaluations also evaluate fellows’ performance. Supervision: Fellows round with faculty twice a month under direct supervision, and twice a month independently under indirect supervision.

6) Teaching methods D. Renal Transplantation

1) Goal: Fellows will become competent in caring for inpatient and outpatient renal transplant patients and evaluating recipients and donors.

2) Objectives: (As described above for general objectives for the program as a whole)

The objectives of the Transplantation rotation are designed to reflect a progressive increase in learning and independence. The learning principles are based on Bloom's taxonomy, describing progression through the six learning domains: knowledge, comprehension, application, analysis, synthesis and evaluation. In practice, the program's objectives change at the completion of the first year of the 2-year training period.

Months 1-12. Fellows function at least at the level of accurate reporting of the history, physical examination, and other data, i.e., they correctly recall and state the relevant facts. Fellows begin to understand or comprehend this information, reviewing and reporting the relevant facts in an organized and efficient manner. Fellows begin to describe how to apply this information to make diagnostic and therapeutic decision. With more experience, Fellows are able to accurately interpret the history, physical examination, and data. The information is analyzed and an accurate differential diagnosis is formulated. Fellows continue in their abilities to design a diagnostic plan and therapeutic interventions.

Months 13-21. Fellows are able to correctly manage patient care. This extends previous expectations

to formulating a correct diagnostic plan, making the correct diagnosis. They should be beginning to critically analyze literature relevant to the care issues.

Month 22-24. Fellows are competent in all six core competencies and have achieved competency in the 23 Milestones. They function as self-educators, reading and analyzing the literature, and adjust their care based on this analysis. They also function as educators in a larger context, using their clinical experience and information they have obtained from the literature to teach their patients, colleagues, staff, and faculty.

Patient characteristics (number, demographics)

Inpatients - The average inpatient renal transplant census at Harbor-UCLA Medical Center is 2-6

patients. Approximately 30-40 patients receive renal transplants at Harbor-UCLA Medical Center each year. Patient demographics are similar to those for our general nephrology patients, with the patient population emulating a minority-majority environment, including significant representation of an underserved population. The average inpatient renal transplant census at the UCLA Medical Center is 25-40 patients. The demographic at the UCLA Center for the Health Sciences closely reflects the demographic of Los Angeles County, which is approximately 44% Hispanic, 33% European-American, 11% African-American, and 12% others. Patients tend to be of middle and upper middle class. The program carries out more than 400 renal transplants a year, which is the primary focus of training. However, there is additional exposure to renal disease in patients with liver, heart, lung and bone marrow transplants.

Outpatients – Over 1,000 patients are followed in the Harbor-UCLA Post-Transplant Clinic. An average of 35 - 40 patients are seen in the weekly Post-Transplant Clinic at Harbor-UCLA. The Pre-Transplant and bi-annual Re-evaluation Transplant Evaluation Clinics evaluate up to twelve patients per session, five days each week. Patient demographics are similar to those for general nephrology patients.

3) Types of clinical encounters and supervision on the Transplantation rotation. Each Fellow spends 3-4 months/year on the Transplantation rotation at Harbor-UCLA Medical

Center. Since we do approximately 30-40 renal transplants/year, in most years, first year fellows may see fewer new transplant patients at Harbor/year than is recommended for optimal training in Transplantation. In order to enhance the exposure to acute transplantation, Fellows also spend one month on the inpatient Transplant service at the UCLA Center for the Health Sciences, where the number of renal transplants is now more than 400/year. Each fellow rotating at UCLA will have the opportunity to see as many as 30 newly transplanted patients in the one month rotation.

1. Inpatient transplant encounters. At Harbor-UCLA, the Fellows assigned to the Renal

Transplantation service at Harbor-UCLA Medical Center focus on inpatient and outpatient transplantation evaluation and management, and transplant recipient evaluations. Supervision. Clinics and rounds are conducted under the direct supervision of the Transplant attendings. Fellows evaluate and treat newly transplanted patients and patients hospitalized for acute or chronic rejections, infection-related complications, or other complications or medical issues in transplant recipients requiring hospitalization. All patients admitted for a new renal transplant at Harbor-UCLA Medical Center are admitted to the Surgical service. The patients are evaluated by the Nephrology Fellow immediately prior to the transplant under the direct or indirect supervision of the Nephrology Transplant Attending Physician to ensure that the patient is medically suitable for transplantation, assuming the cross-match permits. The Nephrology fellow under the supervision of the Nephrology attending also follows the patient during the peri- and post-operative period. The Fellow discusses peri- and post-operative care with the Transplant Surgery Team, and is responsible for writing the immunosuppression orders under the direct or indirect supervision of the Transplant nephrologist. After discharge, any subsequent admissions of renal transplant recipients are made to the Internal Medicine service (unless the problem is likely to require surgery). The Fellow is the primary consultant for these patients, seeing them and writing notes on a daily basis, and for all practical purposes, directing the care of these patients on the Internal Medicine service under the direct or indirect supervision of the Transplant nephrologist. The Fellow makes sit-down interdisciplinary rounds with the renal transplant team in which the patient’s current status and care plan are discussed. The Transplant nephrologist is on-call with the Fellow 24 hours a day providing indirect supervision, usually with direct supervision readily available, for discussion of both routine and difficult transplant issues.

2. UCLA Center for the Health Science Inpatient Transplantation experience. See

description of the Transplant rotation in section 4A.2 and 5C. 3. Outpatient transplant encounters. General post-transplant follow-up clinic.

Demographics are as above for General Nephrology. All fellows attend the General Transplant Clinic on an ongoing basis during the entire clinical training program ½ day per week (Wednesday mornings). An average of 40-45 patients are seen in each clinic. Patients seen may have had their transplants very recently or as long as 30 years ago. This clinic is an opportunity for fellows to learn both the acute outpatient management of patients with a renal allograft and to manage the patient who has had an allograft for decades. Unlike other transplantation programs where there may be pressure to return the patients to the referring physician for post-transplantation management, the vast majority of the patients transplanted

at Harbor-UCLA Medical Center are from our own program and their post-transplant management is continuous with the Transplant team and includes long duration follow-up. Differences in the risk of rejection, the nature of the infections observed over time, and the extra-renal complications and morbidity events are appreciated and managed. Supervision: Each patient is presented to the attending who is in the clinic to supervise and teach. Supervision may be direct or indirect depending on the complexity of the problem and the skills of the fellow.

Recipient evaluations, wait-list follow-up, and live renal donor clinics. Demographics are

as above in for General Nephrology. Fellows on the Transplantation service at Harbor-UCLA Medical Center also have exposure to outpatient transplantation evaluation and management. Fellows receive intensive education on the outpatient evaluation of new transplant referrals, re-evaluation of patients on the waiting list, and evaluations of live renal donors. Since most Nephrologists will not be involved in the acute care of the newly transplanted patient, but instead will be heavily involved in the referral of patients for transplantation, the need to maintain the patients’ care so that the patient is not on the “on-hold” list is also key to the training of a nephrologist. In the case of the live renal donor evaluation, understanding both the ethical issues and the medical issues will help the Nephrologist consultant to explain the results of donor evaluations to patients, and the importance of privacy of potential donors, so we believe that some education in this area is also helpful. We have expanded our education program to some targeted experience in this area. Furthermore, some nephrologists are needed to perform independent evaluations on live Transplant donors. This targeted educational experience may serve to stimulate a trainee to pursue this niche area of practice. Supervision: Each patient is presented to the attending who is in the clinic to supervise and teach. Supervision may be direct or indirect depending on the complexity of the problem and the skills of the fellow.

E. Procedural training Percutaneous biopsy of native kidneys. Supervision. For native renal biopsies, fellows receive

didactic lectures and instruction in ultrasonography initially in a simulation laboratory. This is followed by interpretation during the performance of actual renal biopsies under the direct supervision of the faculty attending physician. Performed by the Fellow on inpatients in conjunction with a Nephrology consultation and on outpatients in whom the decision is made after a diagnostic evaluation by the fellow in the outpatient Nephrology clinics. Each Fellow performs about 10-20 native renal biopsies yearly. Every renal biopsy is performed under the direct supervision of a Nephrology faculty member during the entire clinical training period. In rare circumstances, if a Nephrology faculty member is unavailable for supervision, the biopsy may be referred to Interventional Radiology.

Percutaneous biopsy of renal allografts. Performed by the Fellow when a decision is made for this

diagnostic evaluation on patients either on the inpatient Renal Transplant service or in the Renal Transplant clinic. Each Fellow performs about 10 allograft biopsies yearly. Supervision. Every renal biopsy is performed under the direct supervision of a Nephrology faculty member during the entire clinical training period. In rare circumstances, if a Nephrology faculty member is unavailable for supervision, the biopsy may be referred to Interventional Radiology.

Urinalysis. Performed by the Fellow on most new inpatients and outpatients, and on follow-up

evaluation as necessary. One didactic lecture per year is given. Supervision. Urinalyses are directly reviewed with fellows by faculty on the Consultation service and in the General Nephrology Continuity clinic. Fellows may also perform UA under indirect supervision with direct supervision available.

Renal ultrasound/Catheter placement. Supervision. Fellows receive didactic training in the

performance of renal ultrasonography and of vascular ultrasonography for the performance of venous catheter placement for dialysis, initially in a simulation laboratory, where they are evaluated with a

MiniCEX. Then they are further trained to use ultrasonography for venous catheter placement either by Nephrology faculty, by our certified Nurse Practitioner, and/or by the previously certified PGY5 fellow(s) on the service. This certification process involves the direct observation of at least five catheter placements at the internal jugular and femoral vein sites, or direct supervisory observation until the fellow is deemed competent to perform these procedures independently with indirect supervision and/or indirect supervision with direct supervision available. The Division of Nephrology and Hypertension has its own Ultrasound machine for teaching and clinical use.

Therapeutic plasma exchange (PLEX). Currently performed by the Blood Bank staff. Fellows are

given didactic instruction in PLEX prescription, indications, contraindications, and outcomes, and participate in clinical recommendations in appropriate patients on the Consultation or Transplantation services. A new program is currently under development to use dialysis machines and PLEX filters to provide PLEX treatments for patients with renal indications. This is intended to expand the therapeutic armamentarium of nephrology trainees.

Acute inpatient hemodialysis. Fellows are trained to evaluate patients, determine the indications for

acute hemodialysis, to write appropriate dialysis prescriptions, and to longitudinally evaluate and address complications. Supervision. The fellow evaluates patients for and writes all dialysis orders under the supervision of the Attending Nephrologist. During early fellowship, these are performed under direct supervision, and with progressive expertise and experience of the fellow, this is advanced to indirect supervision.

CRRT. Fellows are trained to evaluate patients, determine the indications for CRRT, and to write appropriate dialysis prescriptions, including the appropriate anticoagulation (eg citrate, heparin, or hemodilution). Supervision. The fellow evaluates patients for and writes all CRRT orders under the supervision of the Attending Nephrologist. During early fellowship, these are performed under direct supervision, and with progressive expertise and experience of the fellow, this is advanced to indirect supervision.

Peritoneal dialysis. Fellows are trained in prescribing peritoneal dialysis including CAPD and CCPD,

and to longitudinally evaluate and address dialysis complications and its comorbidities. As part of our in-depth dialysis course, fellows receive a practicum and didactic education in the technical aspects of PD performance, the pathophysiology of PD, and trouble-shooting complications, including adequacy and infections. Supervision. The fellow evaluates patients for and writes all PD orders under the supervision of the Attending Nephrologist. During early fellowship, these are performed under direct supervision, and with progressive expertise and experience of the fellow, this is advanced to indirect supervision.

Chronic hemodialysis. Fellows are trained to evaluate patients, determine the indications for chronic

hemodialysis, to write appropriate dialysis prescriptions, and to longitudinally evaluate and address dialysis complications and its comorbidities. One feature of our program is for this to be a “continuity” clinic. Fellows are encouraged to provide comprehensive care to ESRD patients on hemodialysis, including primary care that is unique to the dialysis population, transplantation planning, and addressing the socioeconomic and psychological issues that face patients with ERSD on hemodialysis. Fellows take part in a monthly interdisciplinary conference with nurses, social workers, and dieticians to address these needs. Fellows receive monthly “DQI” scores (Dialysis Quality Improvement) for their patients to help them track the progress of their patients and to help them to address specific needs. As part of our in-depth dialysis course, fellows receive a didactic education in the technical aspects of HD performance, in-depth discussion of vascular access, and trouble-shooting complications. Supervision. The fellow evaluates patients for and writes all dialysis orders under the supervision of the Attending Nephrologist. During early fellowship, these are performed under direct supervision, and with progressive expertise and experience of the fellow, this is advanced to indirect supervison, and eventually oversight.

F. Research/CQI/Elective rotation.

(This section refers to the Research expectations for fellows in the Clinical track. The goals and objectives of fellows in the Research track are discussed separately in a later section.)

Goals/Objectives

Research. Within the context of the Clinical training program track, Fellows will develop an understanding and appreciation of the principles, methods, evaluation, and laws governing

research and Continuous Quality Improvement, and will have the experience of carrying out a project that creates new knowledge. Continuous Quality Improvement. In collaboration with a faculty mentor, fellows identify a clinical observation or a process in need of improvement, develop data to accomplish desired

improvement, present the problem and solution at a CQI conference, and use the exercise to improve. Elective. Each fellow has a 2-week elective period during which he or she can, under the guidance of a faculty supervisor, have a focused experience in any area of value to that individual. Examples include extra time for research or the CQI project, or exposure to areas not in the formal curriculum, including Interventional Nephrology, Urology, Pediatric Nephrology, etc. Evaluation. Evaluations by the faculty advisor are submitted in MedHub. On presentation of the CQI and Research projects, conference evaluations are submitted by conference attendees.

The Fellow training evaluation process. The detailed evaluation process described in this curriculum reflects ACGME-mandated changes in the subspecialty training evaluation process beginning July 1, 2014. Training is evaluated using many tools to ensure that the fellow develops longitudinally, acquires proficiency in the 6 competencies (patient care, medical knowledge, system-based practice, practice based learning and improvement, professionalism, interpersonal skills and communication), and cultivates the skills encompassed in the 23 reportable milestones. Graded descriptions of performance are used to evaluate training experiences, behaviors, and knowledge sets, and they are linked to these specific milestones for reporting. These graded evaluations are descriptive in nature, and faculty are encouraged to evaluate using the worded descriptors and not the numerical values. However, in processing the evaluation for computerized analysis, the graded descriptions are translated into numerical scores. Clinical Competency (Evaluation) Committee (CCC) of the Harbor-UCLA Nephrology training program is comprised of the Training Program Director, the Associate Training Program Director, and at least two additional Key Clinical Faculty members. The CCC chair is named by the Training Program Director. The Training Program Director is a non-voting member. The CCC reviews and evaluates each fellows’ learning trajectory and makes recommendations to the Training Program Director semi-annually. The CCC uses in its evaluation of each fellow, the composite of the assessments of the teaching faculty, 360o evaluations (see below), MiniCEX reports, self-evaluation, duty hour surveys, results of the national inservice exam, and the local UCLA-wide inservice exams. The CCC may modify the average values that were obtained by surveying the full faculty. If that occurs, a reason for the change (either higher or lower) will be explained. Under rare circumstances, the Training Program Director may modify the recommendation of the CCC, but also must show cause. The

deliberations of the CCC are summarized and uploaded into MedHub and, as peer-review documents, are subject to peer-review protection. The evaluation tools we use were developed by the American Society of Nephrology (ASN) Training Program Director group. Our CCC made minor modifications to minimize redundancy and to make the evaluations relevant to our specific training environment. To facilitate transparency, fellows can access their personal anonymized evaluations and the evaluation forms online on MedHub. Fellows undergo a formal review process and meet with the Training Program Director quarterly. Two quarterly evaluations (July to September; January to March) are informal and are used to discuss performance and review the Fellow’s progress in meeting the granular scholarly and procedural requirements of the program that need completion before graduation. The other two quarterly evaluations (October to December; April to June) are formal and are the requisite reviews that are used to report to ACGME. For these, the Training Program Director uses the recommendation of the CCC to evaluate and discuss the Fellow’s achievement in the six competencies, reportable milestones, the fellow’s learning trajectory, and particular areas of strengths and weaknesses. During the first 6 months of fellowship, all scores must be at or above “critical deficiencies”; scores below this will be reviewed by the CCC and Program Director. If specific problem areas are identified, an appropriate corrective action plan is developed, and the problem areas are re-evaluated in the next month. Beginning evaluations are expected to be at least “appropriate for a beginning learner”. If non-critical but significant performance issues exist at any of the quarterly evaluations, an action plan is developed and the fellow is re-evaluated by the Program Director in 3 months using the same evaluation measurements as above. In addition, even if no significant issues are identified, goals are established for the fellow to work on over the next 3 months. These goals typically do not reflect needed attention to sub-par performance, but instead are intended to help the Fellow focus efforts on program requirements. For example, faculty may note that the fellow did relatively few native kidney biopsies or that attending comments reflected a need to increase general nephrology knowledge base. Appropriate recommendations to work on these areas would be made, including a suggested plan, and progress evaluated at the next quarterly Program Director review. Fellows review all quarterly evaluations orally with the Program Director and both individuals sign the review form. If significant issues are noted during a quarter that require immediate remediation, the attending immediately communicates this to the Program Director who may either call a special meeting of the Clinical Competency Committee, or meet with the attending and fellow to develop an action plan to immediately address the issue. The Fellow’s performance in this area is then reassessed in one month and reviewed with the Program Director. Description of the Evaluation Tools: ASN evaluation toolkit. Each attending physician who interacts with fellows in specific clinical areas during a quarter evaluates fellows using the ASN toolkit forms modified for our program. The areas evaluated are Inpatient Consultation; Transplantation; Outpatient dialysis; Continuity clinic; and Scholarship. 360o evaluation. This evaluation is completed by patients, renal social workers, renal dieticians, nurses, and technicians in order to give a broad sense of how the fellow delivers patient care and interacts with members of the general nephrology health care interdisciplinary team. It is completed yearly. Fellows review this with the Program Director. Problem areas (scores under "4") are identified and an action plan developed. Fellows with unsatisfactory ratings are reassessed in 6 months with particular attention to these problem areas.

Self-evaluation by Fellows. The process of self-evaluation is important in the Fellow’s development into a competent nephrologist and is intended to help establish a life-long pattern of self-assessment and self-improvement. Consequently, Fellows complete a self-evaluation semi-annually that they review with the Program Director. The goal is for the Program Director and Fellow to develop goals, and related action plans, based on this self-evaluation, so that the Fellow can continue to improve. This self-evaluation is not used to critique fellow performance, but only as a tool to help focus the Fellow’s development and to highlight where the fellows’ view of self is similar to others’ evaluation, and where there may be discrepant observations. Written inservice exams. At the end of the first year, Fellows are given two tests covering the curriculum of the UCLA-wide Pathophysiology course. Their performance is reviewed with the Course Director. General nephrology areas in need of improvement are identified and an action plan is developed to address these. Fellow’s fund of knowledge in these areas is reassessed during the quarterly reviews by the Program Director. In addition, in April of each training year, the fellows take the American Society of Nephrology In-training examination. The test is scored on a %-correct basis, and also on a %-ile basis, the latter adjusted for year of training. Fellows receive a summary of the content areas of their incorrect answers. The results of these tests are reviewed with the Training Program Director, and in a more general programmatic way, at the meeting of the Program Evaluation Committee Annual Program Evaluation. Fellows with unsatisfactory scores develop a remediation plan in consultation with the Training Program Director. Mini-clinical examination (Mini-CEX). These provide direct observation of the fellows’ skills in specific activities. Min-CEX exams are performed in the simulation laboratory for renal biopsy and temporary venous access line placement, outpatient dialysis rounds, renal biopsy, and in the outpatient Nephrology clinic or the inpatient Consultation service. Fellow portfolio. Fellows have a number of additional activities that are reviewed and become part of his/her training portfolio. a) CQI project. The Fellow catalogues over time questions and issues that arose during patient

care activities and identifies, with a faculty mentor, an issue to address. Once a problem is identified, a root cause analysis is performed, an action plan is developed, the rationale expounded (including identifying data sources used), actions taken, and the effect of such interventions assessed. This is presented at the Practice-based Learning and Improvement and Continuous Quality Improvement Nephrology Grand Rounds conference slots.

The purpose of some of the CQI projects is to produce enduring pathways for better system-based practice and/or care. Communication documents generated by CQI projects are intended to be used. Currently, communication documents are available for:

▪ Antibody-mediated rejection; ▪ Post-hospital discharge for PD patients; ▪ Post-hospital discharge for HD patients; and -Clinic home and follow-up instructions

These forms are also available on the Harbor-UCLA Nephology website in a Nephrology Fellows forms folder.

b) Practice Improvement Module (PIM) from ABIM. In place of a fellow or faculty-initiated CQI

project, fellows may participate in the PIM in Hypertension, Specialty Referrals, or other areas. c) Morbidity and mortality conference. Identification of practice and/or system-based problems

contributing to morbidity and mortality is an important aspect of meeting these core competencies. Fellows attendance at these conferences, and identification of the issues

discussed and actions taken, is documented and included in the portfolio. These cases are also presented at the Monday Nephrology Grand Rounds conference.

d) Practice-Based Learning and Improvement presentations are performed, with a targeted

content, a pre-test and post-test question, and documentation of the literature cited to answer the question. These presentations assist in improving the fellow's practice, detailing how they researched a topic relevant to a case they encountered and how such research impacted their care, or plan for subsequent care. The topics covered are listed in the portfolio and the actual presentations are maintained as files in the portfolio.

e) Question-Oriented Learning conference. Faculty and fellows, in turn, either create questions

or use published questions from established sources such as NephSAP or MKSAP, and discuss answers. This conference is intended to provide didactic information about medical knowledge and clinical decision-making using brief questions as the format for learning, simulating a board examination style. The presenters’ choice of questions and discussion of the answers are evaluated.

f) Log of adverse events and actions taken. Adverse events are discussed with the Training

Program Director during the quarterly evaluation conversation. g) Monthly Dialysis Clinical Quality Improvement. Each fellow is provided a copy of his/her

achievement of individual patient chronic dialysis practice accomplishments in meeting clinical goals monthly in the hemodialysis facility. Review of these dialysis quality indices (DQI) are intended to enhance the felows’ ability to identify clinical problems and enhance successful clinical interventions. Results are discussed in a monthly interdisciplinary conference.

h) Procedures. Fellows keep a log of native and allograft kidney biopsies, and femoral and

internal jugular vascular access catheters, indicating date, attending, patient identifier, indication and complications. Catheter placement supervisiont. All fellows are supervised by attending physicians in the simulation laboratory, and evaluated by a MiniCEX. Initial catheter placements for patients are performed under the direct supervision of certified operators until competency is achieved, and then may be performed under indirect supervision. Most renal fellows begin Nephrology fellowship having been certified for central line placement by their Internal Medicine programs. Nevertheless, we re-ascertain competence at the start of the fellowship program. Procedure logs are reviewed with the Program Director on a quarterly basis. Copies of the Procedure logs are kept in the Fellow’s electronic file. Renal biopsies. All fellows are supervised by attending physicians in the simulation laboratory, and evaluated by a MiniCEX. Biopsies for patients are always performed in the presence of an attending physician providing direct supervision, regardless of fellow competency and experience.

i) End of first year evaluation. This evaluation includes a review of the Fellow’s performance

during the first year of education, and verifies that the Fellow demonstrated sufficient professional ability to advance to a greater degree of autonomy. This includes the opportunity to proctor catheter placement by first year fellows; participation as a lecturer in the Core Lecture series that the Division gives to Internal Medicine residents rotating on the Nephrology consultation service; more autonomy in deciding the level of detail necessary to present to the attending during weekend call; more oversight of the assignment of patients and initial evaluation of the Internal Medicine residents who rotate on the consultation service; and an expectation to complete a CQI project and presentation and a Nephrology Grand Rounds on the content of their research project.

j) Final (summative) evaluation. This evaluation includes a review of the Fellow’s performance

during the final period of education, and verifies that the Fellow demonstrated sufficient professional ability to practice competently and independently.

Summary of Evaluation Tools (Transplant, Consultation, Clinics, Outpatient Hemo and Peritoneal Dialysis, Scholarship) – Progressive expectations, Months 1-12, 13-21, and 22-24 Evaluation forms can be viewed at https://harbor.medhub.com/index.mh We expect Fellows’ minimum performance to be at the level of “appropriate for beginning learner” during the first 6 months. After that, we would expect a graduated progressive improvement in performance through mid-level, and then to independent performance. In some cases, “aspirational” performance will be noted in areas where Fellows are performing exceptionally well. Didactic learning

a. Conferences. The training program organizes and/or participates in the following conferences: Nephrology Grand Rounds, Practice-Based Learning and Improvement conference, Clinical and Basic Science Journal clubs, Medical Grand Rounds, UCLA-wide Pathophysiology conference, Research conference, Introductory Crash Course for fellows, Renal Pathology conference, and In-depth hemodialysis course. In addition, the Renal Transplant service also provides a Weekly Transplant conference during which renal transplant issues are covered in detail in the didactic conference held each Wednesday just prior to the start of the Transplant clinic. Sessions are devoted to recipient evaluation, mechanisms of allograft rejection, immunosuppressive drugs, prophylaxis and treatment of graft rejection, non-rejection causes of graft dysfunction, major causes of post-transplant morbidity and mortality, and renal disease associated with liver, heart and bone marrow transplantation; and Combined Renal Transplant/Infectious Diseases Conference during which classical, as well as unusual infectious disease complications are presented and discussed by the Renal Fellow and the Infectious Disease Fellow in a joint presentation. Nephrology Transplant and Infectious Disease faculty are also both in attendance to facilitate discussion.

E. Special areas - It is critical to emphasize the importance of psychosocial and economic issues confronting patients with renal disease, ethical issues relevant to the care of patients with renal disease, optimizing the relationship of the nephrologist with other health care providers, and optimizing mechanisms towards achieving life-long learning as a nephrologist. These issues are covered in detail above, however, they are not always clearly identified in the curriculum’s goals as being of paramount significance. In addition, formal lectures on statistics and epidemiology, geriatric evaluation, nursing home care, the transition from Pediatrics and Adolescent Nephrology care to Adult Nephrology care, the physiology and pathophysiology of pregnancy, CKD and ESRD pharmacology, and dialysis discontinuation/end-of-life issues are offered. These special aspects of the curriculum are discussed below, and the instruction may be experienced in the context of the Nephrology Grand Rounds, Medical Grand Rounds, Journal Club, Pathophysiology course, or a special lecture given by a visiting professor:

a. Dialysis initiation, discontinuation and end-of-life issues. Fellows are given at least one one-

hour lecture on dialysis discontinuation and end-of-life issues. In addition, the issues surrounding dialysis initiation are discussed. These issues are also addressed on the inpatient service and in the clinics. The RPA/ASN Clinical Practice Guidelines for Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis form part of the discussion basis.

b. Geriatric assessment. Fellows are given at least one hour of didactic lectures devoted to the physiology and pathology of the aging kidney, altered drug metabolism with aging, and drug toxicity in the elderly.

c. Medical ethics. Fellows attend at least one one-hour lecture during the course of their fellowship devoted to renal-related ethical issues. These focus on dialysis initiation and withdrawal, dialysis funding, renal transplant donor and recipient selection, kidney transplant availability, and other renal-related issues. The social and economic impact of their decisions and the need to be the

patient’s advocate are discussed. All fellows performing clinical research will obtain education and certification in HIPPA rights and the ethical conduct of research.

d. Health care policy and legal medicine. In addition to health policy issues related to end-of-life care, fellows attend at least one one-hour lecture on health care policy and legal medicine, focusing on dialysis and renal transplant.

e. Physician impairment, risk management, patient safety. At the time of initial hire, all fellows spend two days in Hospital orientation with trainees from other disciplines. During this time, they are given instruction in physician impairment, sleep disturbance, OSHA, infection control, risk management, handoff procedures, and HIPAA compliance, which is reiterated to them by the Program Director.

f. Quality assessment and quality improvement. These processes are addressed by relevant projects as described in each section (General Nephrology, Transplant and Dialysis) above. Each fellow provides Practice-Based Learning and Improvement discussions, a Continuous Quality Improvement Project, and a Mortality and Morbidity discussion. Along with Question-Oriented Learning sessions, these form the subjects of the Monday 1:30 PM Fellows Practice-Based Learning and Improvement weekly conference.

g. Medical genetics. Fellows are given several lectures focusing on renal-related medical genetics issues, including discussion of relevant techniques, single gene mutations, and single nucleotide polymorphic disorders. These issues are also covered in Journal Club.

h. Pain control. The California Board of Medical Quality Assurance has required 12 hours of CME for license renewal, so this is handled outside of the scope of the training program by independent study.

i. Transition from Pediatrics and Adolescent Nephrology care to Adult Nephrology care. Fellows attend at least one one-hour lecture during the course of their fellowship devoted to adolescent to adult care transition, with special attention to medical and psychosocial differences.

j. Physiology and pathophysiology of pregnancy. Fellows attend at least one one-hour lecture during the course of their fellowship devoted to the function and malfunction of the kidney in pregnancy. Fellows keep a log of women that they have followed during pregnancy.

k. CKD and ESRD pharmacology issues. Fellows attend at least one one-hour lecture during the course of their fellowship devoted to special considerations regarding drug dosing in CKD, nephrotic syndrome, ESRD and in patients receiving dialysis and CRRT.

l. Log-in directions for the Monday afternoon Pathophysiology conference

m. Research courses – All Fellows participating in clinical research are required to take an online

course in HIPPA regulations and on the ethics and laws governing clinical research. The courses are followed by two examinations, which, upon successful completion, results in the awarding of a certificate in each area.

Fellows are required to complete the courses in Column 3 under “Biomedical Research” but are

welcome to take other modules if they wish. Modules can be found at https://www.citiprogram.org

Fellows with an interest in academic medicine may also take a course given by the UCLA-wide NIH-sponsored Clinical and Translational Science Institute, which includes the following topics:

Introduction to hypothesis testing- power and limitations of p value Analysis of continuous variables - T-test, ANOVA, linear regression Analysis of categorical variables - Chi-square. logistic regression Survival analysis Interpreting studies on therapeutic benefit

Interpreting studies on harm Interpreting studies on diagnostic tests Interpreting studies on cost-effectiveness In addition, fellows with a primary interest in basic science research are encouraged to attend the weekly Tuesday Basic Science Lecture series held in the CTSI Liu Building. The Program Evaluation Committee (PEC) Given the small size of our training program, it was appropriate for all fellows and faculty to be members of the PEC. In accordance with the requirements set forth by the ACGME, the PEC plans, develops, implements, and evaluates the overall educational activities of the training program. It modifies competency-based curriculum goals and objectives through the prism of an annual program review using formal and systematic evaluations by faculty and fellows as the basis for change. The PEC creates plans for program improvement and monitors and tracks the progress of these plans. Powerpoint files reflecting the issues discussed and plans of correction are distributed to all fellows and faculty. Although the formal ACGME-mandated meeting occurs generally in June in order to capture data from the inservice exam, an additional, more informal meeting is also held in December or January to ensure that the faulty and fellows are comfortable that the program is “on the right track” and that no new issues requiring attention have emerged. Assessments and evaluations of the program, fellows, and faculty for use by the PEC

1. Evaluations of faculty and training program. Fellows complete an online ACGME survey annually that confidentially evaluates the overall satisfaction with faculty supervision and the training program. These evaluations are reviewed in a blinded manner by the Training Program Director and are presented for discussion at the Program Evaluation Committee meeting in June. 2. Performance of trainees on ASN inservice exam are reviewed in an anonymized

fashion. 3. Faculty evaluation of the program. Faculty complete an online ACGME survey annually that

confidentially evaluates the overall satisfaction with the training program. Any changes in the program that are made as a result of the review are documented. The June meeting serves as the ACGME-mandated Annual Program Evaluation.

Nephrology Research Training Program A. Research options in the Harbor-UCLA Fellowship program. There are two separate research

tracks, one for fellows seeking a clinical career and a separate track for fellows seeking a career in research. For those fellows at Harbor-UCLA Medical Center whose goal it is to enter the clinical practice of nephrology, research is conducted generally during 2 months, on average, in designated blocks. For those individuals who are planning a career in academic medicine, individualized programs are designed to meet the Fellow’s specific needs. One to three years of time devoted specifically to research has been provided, with designated time for attending didactic courses at local colleges and research institutes, attending courses offered by the NIH-supported UCLA-wide Center for Translational Science Institute (CTSI), weekly lab meetings with a designated mentor, laboratory journal clubs separate from the Divisional journal clubs, and performance of research projects under the guidance of faculty mentors who meet with the Fellow. All fellows are able to choose their own mentors and projects. These two tracks are described in more detail below.

(1) Research Curriculum for Clinical Fellows seeking a clinical career: Fellows meet with faculty to discuss possible research projects and mentorship. Fellows may

become involved in projects already in progress and may not necessarily be responsible for completely designing a new project, but, in some instances, may be able to do so. Clinical fellows are not expected to obtain independent funding to support their salary or research activities. After identifying a mentor and project, Fellows are actively involved in the research project under the direction of the faculty mentor during the times allotted for research. Additional time may be devoted to this during the Elective rotation if the fellow wishes. Thus, during the two years of fellowship, on average each Fellow with a clinical nephrology career trajectory is assigned 2 months to mentored research.

(a) Goals and Objectives of Research Program: i. Understand fundamentals of research including basics of research design, data analysis

(biostatistics), public policy, economics, health education, designing trials, recruiting subjects, responsible use of informed consent, standards of ethical conduct of research, clinical epidemiology, outcomes analysis, and in the case of the basic research trainee, an understanding of the basic science area, techniques, study design, and interpretation.

ii. Gain hands-on experience with conducting a clinical or basic research project including research design (where feasible), data analysis, subject recruitment, data collection, and manuscript preparation.

iii. Understand principles of abstract and paper writing. iv. Provide sufficient exposure to research to allow Fellows to make an informed decision

about pursuing a career involving research. v. Provide sufficient exposure to research to allow Fellows to critically assess basic and

clinical research literature and to be competent in using available medical informatics systems. Bibliographic retrieval and critical appraisal skills are of paramount importance.

vi. Become a co-author on an abstract or published manuscript, or present research at a national meeting.

vii. Give a Nephrology Grand Rounds lecture at the end of Year 2 based on the Fellow’s research project

(b) Didactic Training:

i. Division of Nephrology and Hypertension Clinical Research on-line course provided by the Los Angeles Biomedical Research Institute. Fellows perform self-directed on-line study on HIPPA and ethics in research using a curriculum available on-line or in hardcopy form at the Parlow Library, and take on-line tests leading to certification.

(c) Nature of Supervision: Fellows select a project and mentor, which must be approved by the Nephrology Fellowship

Training Program Director. The Fellow’s research activities will then be guided by the Research Mentor. This involves frequent meetings between the Fellow and mentor during which all aspects of conducting the research projects are addressed.

The research Mentor-Fellow relationship is the primary means by which Fellows will achieve training in research and will include experience that results in an understanding of fundamentals of research including basics of research design, data analysis (biostatistics), public policy, economics, health education, designing trials, recruiting subjects, responsible use of informed consent, standards of ethical conduct of research, clinical epidemiology,

outcomes analysis, and in the case of the basic research trainee, an understanding of the basic science area, techniques, study design, and interpretation.

(d) Means of Fellow Evaluation: The mentor provides the Fellow with ongoing informal feedback. The Training Program

Director also discusses the research progress with the Fellow during their meetings. Evidence of successful completion of the Fellow research requirement includes presenting an abstract at a national meeting, publishing an abstract or manuscript, and/or presentation of the research to the Division of Nephrology and Hypertension at Nephrology Grand Rounds.

(2) Research Curriculum for Fellows seeking a career in academic medicine:

(a) General description.

For fellows entering Nephrology training knowing that they are seeking a career in academic medicine, this track offers one year of clinical training and two years of basic or clinical research. The clinical year is structured so that it is identical to the clinical experience of a year in the two year clinical fellowship. However, we built in some curricular flexibility, for those who decide on an academic career after completing 2 clinical years. Fellows may, after two years of clinical training in Nephrology, also elect to enter research training in this track. Thus, our advanced nephrology (academic/research track) fellowship is a two-year research program spent before or after the 1-2 years of regular clinical fellowship training. The two years of research are spent under the direction of a faculty member within the Division of Nephrology and Hypertension. The two years of research are spent under the direction of a faculty member within the Division of Nephrology and Hypertension. Fellows meet with research faculty to discuss possible research projects and mentorship. After identifying a mentor and project, Fellows are actively involved in the research project under the direction of the faculty mentor. Ten per cent of the time during the academic research years are spent in clinical activities, either at a continuity clinic or at dialysis rounds under the supervision of a faculty mentor. Fellows anticipating a career in academic medicine are expected to actively participate in the writing of grants for the support of the research training. However, for such individuals, the Division will, whenever possible, make a commitment for salary support in the event such a grant is not obtained for a promising individual and project after an appropriate effort is made.

(b) Goals and Objectives for Training:

GOALS:

Understand fundamentals of research including basics of research design, data analysis (biostatistics), public policy, economics, health education, designing trials, recruiting subjects, responsible use of informed consent, standards of ethical conduct of research, clinical epidemiology, outcomes analysis, and in the case of the basic research trainee, an understanding of the basic science area, techniques, study design, and interpretation.

Develop expertise in conducting a clinical or basic research project including research design, data analysis, subject recruitment, data collection, laboratory skills (as appropriate), and manuscript preparation.

Understand principles of grant and paper writing.

Develop expertise in the critical assessment of basic and clinical research literature

Develop competence in using medical informatics systems. Bibliographic retrieval and critical appraisal skills are of paramount importance.

Author a manuscript or abstract, or present research at a national meeting.

With research project fruition, submission of a K award with a faculty mentor is encouraged

OBJECTIVES:

In the first year, trainees should become familiar with the methods and problems inherent in performing and interpreting clinical and basic science research. Fellows will accomplish this through participation in the design, performance, and interpretation of their research projects under the guidance of one or more mentors.

In the second year, trainees will acquire further knowledge and understanding of the research methodologies with more independent hypothesis development, experimental design, statistical analysis, and preparation of data for publication.

Fellows are expected to submit paper(s) for publication and submit grants to support future research.

(c) Didactic training

CTSI courses. Fellows are expected to attend CTSI-sponsored courses. Topics covered include basics of research design, ethical conduct of research, responsible use of informed consent, data analysis (biostatistics), public policy, economics, health education, designing trials, recruiting subjects and other epidemiology issues, and outcomes analysis. Research fellows are encouraged to enter the Clinical and Translational Science Institute (CTSI) Training Program for Translational Science (TPTS) Track 2 at the Geffen School of Medicine at UCLA. Upon successful completion, fellow will be awarded a CTSI TPTS Research Certificate. Fellow will master the fundamental skills, methodologies, theories, laws, ethics, and conceptualizations of translational clinical investigation. Fellow will take the following courses:

Clinical and Translational Design and Analysis

• Biomath M262: Communication of Science (Grant Writing). • Biomath 259: Controversies in Clinical Trials. • Biomath M261: Responsible Conduct of Research Involving Humans. • Biomath 170A: Introductory Biomathematics for Medical Investigators • Biomath 266A: Applied Regression Analysis in Medical Sciences • M263: Clinical Pharmacology. Responsible Conduct of Research • The Scientific Method and Research Misconduct. • Protecting Human Study Volunteers; Practical Issues in the Conduct of Research (IRB101). • Research Integrity and Ethics in Cell and Molecular Biology (Chem 203A). • Ethics and Accountability in Biomedical Research; The basics for new investigators.

(d) Supervision and Evaluation

Nature of Supervision: Fellows select a project and mentor, which must be approved by the

Nephrology Fellowship Training Program Director. The fellow’s research activities will then be guided by the research mentor. This involves frequent meetings between the Fellow and mentor during which all aspects of didactic learning progress and conducting the research projects are addressed.

Means of Fellow Evaluation: The mentor provides the fellow with ongoing informal and formal

feedback. In addition, the mentor meets with the Nephrology Training Program Director to report on the Fellow’s progress. The Training Program Director also discusses the research progress with the fellow during their semi-annual meetings. Evidence of successful completion of the fellow research requirement includes presenting an abstract at a national meeting, publishing a manuscript, and/or presentation of the research to the Division of Nephrology and Hypertension for the one hour research conference. Ideally, the fellow will write grants and successfully compete for internal or external funding.

(e) Program Certifications: The Advanced Nephrology Program is accredited by the Graduate Medical Education Committee of the Harbor-UCLA Medical Center and is part of our ACGME-accredited clinical nephrology fellowship.

Clinical Competency (Evaluation) Committee. Revised. Oct 3, 2018 Adapted from: https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRResidency2019.pdf V.A.3.b) The Clinical Competency Committee: V.A.3.b).(1) Reviews all fellow evaluations at least semi-annually; (Core) V.A.3.b). (2) Determines each resident’s progress on achievement of the Nephrology Milestones; and (Core) V.A.3.b).(3) Meets prior to the residents’ semi-annual evaluations to advise the program director regarding each fellow’s progress Guidelines for Promotion and Graduation A. Clinical Track. 2 year clinical fellowship (1) Promotion from 1st to 2nd year. This evaluation includes a review of the Fellow’s performance

during the first year of education, and verifies that the Fellow demonstrated sufficient professional ability to advance to a greater degree of autonomy. This includes the opportunity to proctor catheter placement by first year fellows, participation as a lecturer in the Core Lecture series that the Division gives to Internal Medicine residents rotating on the Nephrology consultation service, more autonomy in deciding the level of detail necessary to present to the attending during weekend call, more oversight of the assignment of patients and initial evaluation of the Internal Medicine residents who rotate on the consultation service, and an expectation to complete and present a CQI project, Mortality and Morbidity conference,and Nephrology Grand Rounds on the content of a research project.

(2) Graduation. This evaluation includes a review of the Fellow’s performance summtively and during the final period of education, and verifies that the Fellow demonstrated sufficient professional ability to practice competently and independently.

Dealing with unsatisfactory Fellow performance.

This information is provided in the unlikely event that a serious non-remediable problem is encountered with a Fellow. Fortunately, this is an extremely rare event in the Division of Nephrology and Hypertension at Harbor-UCLA Medical Center. In the event of a repeated unsatisfactory rating (failure to improve despite counseling and supervision), the Fellow meets with the Clinical Competency Committee to discuss his/her deficiencies. Written documentation is made of these meetings. If the Clinical Competency Committee deems the Fellow’s deficiencies severe enough, because of clinical incompetence or inability to exhibit professional attitudes, then the Fellow will be placed on probation. Short of probation, the Clinical Competency Committee may, in certain cases, require counseling for that Fellow. The Fellow will be advised of specific steps required to correct the stated deficiencies. One month later, the Fellow will be re-evaluated by the Clinical Competency Committee and written documentation made. If correction is not seen at this point, the Clinical Competency Committee will meet with all Nephrology faculty to make a decision whether to refuse to renew a Fellow's contract at the end of the year or to refuse to sign off on the Fellow's training. These discussions will be shared with the Harbor-UCLA GMEC prior to final action. At any time, a Fellow may express a grievance in writing either by requesting to meet all full-time faculty or entering the appeal process of the GMEC via the Director of the GMEC or the Chair of the Department of Internal Medicine.

Program Evaluation Committee (PEC) description. Revised. Oct 3, 2018 The description of the PEC for the Harbor-UCLA Nephrology training program, described below, is adapted from: https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRResidency2019.pdf V.C.1.c) The Program Evaluation Committee develops, evaluates, re-evaluates, and revises:

V.C.1.c).(1) The curriculum; V.C.1.c).(2) Outcomes from the prior Annual Program Evaluation(s); V.C.1.c).(3) ACGME letters of notification, including citations, Areas for Improvement, and comments; V.C.1.c).(4) Quality and safety of patient care; V.C.1.c).(5) Aggregate resident and faculty:

V.C.1.c).(5).(a) Well-being; V.C.1.c).(5).(b) Recruitment and retention; V.C.1.c).(5).(c) Workforce diversity; V.C.1.c).(5).(d) Engagement in quality improvement and patient safety V.C.1.c).(5).(e) Scholarly activity; V.C.1.c).(5).(f) ACGME Resident and Faculty Surveys; and, V.C.1.c).(5).(g) Written evaluations of the program.

V.C.1.c).(6) Aggregate resident: V.C.1.c).(6).(a) Achievement of the Milestones; V.C.1.c).(6).(b) In-training examinations; V.C.1.c).(6).(c) Board pass and certification rates; and V.C.1.c).(6).(d) Graduate performance.

V.C.1.c).(7) Aggregate faculty: V.C.1.c).(7).(a) evaluation; and, V.C.1.c).(7).(b) professional development.

V.C.1.d) The Program Evaluation Committee evaluates the program’s mission and aims, strengths, areas for improvement, and threats.

V.C.1.e) The annual review, including the action plan, is: V.C.1.e).(1) Distributed to and discussed with the members of the teaching faculty and the fellows; and V.C.1.e).(2) Submitted to the DIO.

V.C.2. The program completes a Self-Study prior to its 10-Year Accreditation Site Visit. V.C.2.a) A summary of the Self-Study is submitted to the DIO.

Nephrology Fellowship Work, Duty Hours, Moonlighting and On-Call Policy A. Work and duty hours (1) ACGME requires that Fellows work no more than 80 hours per week averaged over a 4-week

period. Our program adheres to these guidelines.

(2) Fellows are required by ACGME to be free of all work obligations for one day out of seven averaged over a 4-week period. The Division strictly adheres to this policy. In reality, Fellows are free of all work obligations for substantially more than the ACGME-required minimum.

(3) The ACGME requires that adequate time for rest and personal activities is provided by a 10-hour time period between all daily duty periods and after in-house call. There is no in-house call (see C. below). Fellows may have to return at night to the hospital from home while on call. However, all fellows share this call.

(4) On some nights, an on-call attending physician will round on patients during the day and/or take emergency calls at night. It is the responsibility of fellows to ensure for responsible hand-offs to the outside attending and to receive handoffs from the outside attending. It is also the responsibility of fellows to forward pages from the fellow on-call beeper to the attending on-call beeper at the start of handoff to the attending, and to re-set it to the fellow beeper at the end of the attending shift.

Instructions for forwarding pages from 310-501-0500 to the On-call Attending:

Open page: https://www.spok.com

Click on my account on the top of the page, and then click on my account login highlighted in red

in the middle of the page

Enter user name: harbor2 and password: Humc1234 (Capital H) to login to the account

On the left side of the page, enter your device number: 310-501-0500 then click search, you will

see a picture of a pager with our device features

Under user options, Click MSG CARBON COPY/FWD

Under forward address, enter the on-call attending pager number, and or email address, then click

update

B. Moonlighting. The Division of Nephrology and Hypertension recognizes that fellow moonlighting

can be complementary to the fellowship training experience. However, any fellow choosing to moonlight must do so with the clear understanding that fellowship training is their first priority and any actions interfering with the fellowship training program are strictly prohibited. Each moonlighting activity must be approved in advance by the program director after being provided with a written description of the specific moonlighting activity, hours, and frequency. This reporting must be completed and approval obtained from the Program Director before any moonlighting can begin. The following restrictions apply to fellow moonlighting:

The fellow must be performing satisfactorily in the program.

If a fellow chooses to “moonlight,” he or she is responsible for their own liability coverage. Even if this activity is being performed at Harbor-UCLA Medical Center, or an affiliated hospital, and/or additional compensation is being provided to the fellow, it is outside the scope of a fellow’s duties as a Nephrology trainee. The fellow should not wear a Harbor-UCLA Medical Center lab coat or nametag while moonlighting outside of Harbor-UCLA Medical Center.

If the fellowship Training Program Director feels that the fellow’s “good standing” is at risk by the time spent moonlighting, he or she can prohibit such moonlighting even without placing the fellow on probation. This action and an explanation for it must be transmitted to the fellow both in person and in writing and to the fellow’s file.

As per GME regulations, fellows should not work more than 80 hours a week, when averaged over a four week period. Hours worked include training program hours and moonlighting hours.

Fellows may not moonlight while on-call.

C. On-call schedule. Fellows will be on-call about one out of four weekdays during the 2017-18

academic year. All call is from home; there is no in-house call. Until July 2017, fellows were on call once every six weekends. Beginning July 2017, in order avoid fatigue and to prevent call time from interfering with learning, two fellows will be on call over the weekend (5 PM Friday to 8 AM Monday). The short-call fellow saw ICU and renal transplant patients. It is anticipated that this call could be completed by noon on Saturdays and Sundays. The long-call fellow saw new consults and non-ICU consult patients who require follow-up over the weekend.

In 2017-18, weekday call is from Monday to Thursday from 5 PM until 8 AM the next morning. The On-call fellow sees and writes notes and orders on patients on the Nephrology Consult and Transplant Services. On Friday, the Consult team, under the supervision of the Consult attending, develops a “handover” list of the Consult patients who need to be seen and evaluated and have notes written over the weekend. Physical notes covering this handover are created using the Harbor-UCLA Medical Center electronic format for handover reporting. On-call fellows must present all patients to the On-call attending nephrologists on Friday evening and Sunday morning. On Saturdays and weekday nights, fellows must present any acute dialysis to the On-call attending nephrologist over the weekend and on weekday nights. One or two Internal Medicine residents are typically on the Nephrology Service at any time, but Internal Medicine residents do not take Nephrology call. Nephrology Attending physicians are responsible for supervising all care provided to inpatients and outpatients. Attending physicians are on-call 24 hours a day, providing teaching and back-up to the Fellow with direct, indirect or indirect with direct availability as needed.

D. Vacation. Fellows receive four weeks of paid vacation each year. These are scheduled according

to fellow requests in the yearly schedule.

E. Two examples of the monthly call schedule are as follows. For their first weekend call, first year

fellows are paired with a more senior fellow or nurse practitioner. During weekends and weekdays, there is always an attending on call.

HARBOR-UCLA MEDICAL CENTER NEPHROLOGY AND HYPERTENSION

CALL SCHEDULE MONTH OF: SEPTEMBER, 2018

DATE DAY ON-CALL

BEEPER

STAFF TRANSPLANT

STAFF

DIALYSIS

NURSES

LONG CALL

SHORT CALL

DIRECT

PATIENT CARE

SUPERVISORY

1 SAT 501-0500 DAI BARBA CHOI AKRAM DOAN

2 SUN 501-0500 MAPARA | | MAPARA MAPARA

3 MON 501-0500 DAI | | PATEL NIEVES-BORRERO

4 TUES 501-0500 ADLER | ZAMORA NIEVES-BORRERO DOAN

5 WED 501-0500 | | | DOAN AKRAM

6 THUR 501-0500 | | SARMIENTO AKRAM PATEL

7 FRI 501-0500 MAPARA | CHOI MAPARA MAPARA

8 SAT 501-0500 DAI | | AKRAM NIEVES-BORRERO

9 SUN 501-0500 MAPARA | | MAPARA MAPARA

10 MON 501-0500 ADLER | | AKRAM PATEL

11 TUES 501-0500 | | ZAMORA PATEL NIEVES-BORRERO

12 WED 501-0500 | | | NIEVES-BORRERO DOAN

13 THUR 501-0500 | | SARMIENTO DOAN AKRAM

14 FRI 501-0500 CHAN | CHOI CHAN CHAN

15 SAT 501-0500 DUKKIPATI | | NIEVES-BORRERO AKRAM

16 SUN 501-0500 CHAN | | CHAN CHAN

17 MON 501-0500 ADLER | | PATEL AKRAM

18 TUES 501-0500 | | ZAMORA AKRAM PATEL

19 WED 501-0500 | | | DOAN NIEVES-BORRERO

20 THUR 501-0500 DAI | SARMIENTO NIEVES-BORRERO DOAN

21 FRI 501-0500 CHIVANGKUL | CHOI CHIVANGKUL CHIVANGKUL

22 SAT 501-0500 DAI | | DOAN PATEL

23 SUN 501-0500 CHIVANGKUL | | CHIVANGKUL CHIVANGKUL

24 MON 501-0500 DAI | | NIEVES-BORRERO PATEL

25 TUES 501-0500 | | ZAMORA PATEL DOAN

26 WED 501-0500 | | | DOAN AKRAM

27 THUR 501-0500 | | SARMIENTO AKRAM NIEVES-BORRERO

28 FRI 501-0500 MAPARA** | CHOI MAPARA** MAPARA**

29 SAT 501-0500 DAI | | PATEL NIEVES-BORRERO

30 SUN 501-0500 MAPARA** | | MAPARA** MAPARA**

NOTE: CALLS FROM HEMODIALYSIS AND TRANSPLANT PATIENTS SHOULD BE REFERRED TO THE CALL FELLOW

HARBOR-UCLA MEDICAL CENTER NEPHROLOGY AND HYPERTENSION

CALL SCHEDULE MONTH OF: AUGUST, 2009

DATE DAY 1st CALL

FELLOW

ON-CALL

FELLOW

BEEPER

STAFF TRANSPLANT

STAFF

DIALYSIS

NURSES BACKUP FELLOW

2ND CALL

1 SATURDAY PARK 501-0500 ADLER BARBA PAIK NASSERI

2 SUNDAY | 501-0500 | | | |

3 MONDAY MEHTANI 501-0500 | | |

4 TUESDAY NASSERI 501-0500 | | |

5 WEDNESDAY CHAMBERLIN 501-0500 | | FERNANDO

6 THURSDAY PARK 501-0500 | | |

7 FRIDAY MEHTANI 501-0500 | | ALMAZAN CHAMBERLIN

8 SATURDAY | 501-0500 | TONG | |

9 SUNDAY | 501-0500 | | | |

10 MONDAY NASSERI 501-0500 | | PAIK

11 TUESDAY CHAMBERLIN 501-0500 | | |

12 WEDNESDAY SHAH 501-0500 | | SOLIS-JAVIER

13 THURSDAY PARK 501-0500 HIRSCHBERG | |

14 FRIDAY SHAH 501-0500 | | FERNANDO PARK

15 SATURDAY | 501-0500 | | | |

16 SUNDAY | 501-0500 | BARBA | |

17 MONDAY MEHTANI 501-0500 | | ALMAZAN

18 TUESDAY NASSERI 501-0500 | | |

19 WEDNESDAY SHAH 501-0500 | | FERNANDO

20 THURSDAY PARK 501-0500 | | |

21 FRIDAY CHAMBERLIN 501-0500 | | SOLIS-JAVIER MEHTANI

22 SATURDAY | 501-0500 | | | |

23 SUNDAY | 501-0500 | | | |

24 MONDAY RIZVI 501-0500 | | ALMAZAN

25 TUESDAY MEHTANI 501-0500 ADLER | |

26 WEDNESDAY RIZVI 501-0500 | | SOLIS-JAVIER

27 THURSDAY CHAMBERLIN 501-0500 | | |

28 FRIDAY NASSERI 501-0500 HIRSCHBERG | PAIK SHAH

29 SATURDAY | 501-0500 | | | |

30 SUNDAY | 501-0500 | | | |

31 MONDAY RIZVI 501-0500 | | ALMAZAN

NOTE: CALLS FROM HEMODIALYSIS AND TRANSPLANT PATIENTS SHOULD BE REFERRED TO THE CALL FELLOW

F. Policies regarding medical leave, family leave, maternity leave, leave for examinations, educational leave, sexual harassment, physician impairment and disability, jury duty, counseling services, and grievance procedures can be found in the Harbor-UCLA Medical Center Housestaff Policies and Procedures Manual. Access to this manual through MedHub is described to all new Fellows at orientation during the first week of Fellowship.

G. There is no liability insurance by the Harbor-UCLA Medical Center for clinical activities outside the

State of California or outside the country. Fellows will, therefore, perform all clinical activities in the State of California.

Nephrology Fellow Stipend and Benefits A. Fellows are paid PGY4 and PGY5 salaries according to the County of Los Angeles and Harbor-

UCLA Medical Center policy. Salary pay scales are paid by and determined by the Board of Supervisors of the County of Los Angeles.

B. Benefits include malpractice insurance, medical insurance, and dental insurance for the Fellow,

group life insurance, 24-hour accident insurance, and long term disability insurance. Additional

insurance to cover family members may be purchased by the Fellow. More details can be found in the Harbor-UCLA Medical Center Housestaff Policies and Procedures Manual.

C. Fellows are provided with the following: (1) Pager (2) An office in the hospital (shared with other fellows) (3) Journal subscriptions and handouts (see Curriculum) (4) Access to Up-to-Date (5) One trip to a professional meeting. Policy on Fellow Teaching and Supervision of Residents. Fellows interact with Internal Medicine

residents on the inpatient wards, on the renal consultation service, during clinics, and in division conferences. Fellows are expected to behave in a professional manner towards residents. This includes answering resident questions to the best of the Fellow’s ability, directing the resident towards known appropriate learning resources, and notifying residents of the timing of attending rounds each day (since the time may change from day to day). Fellows may teach residents as they are able, but the burden of resident teaching, as it relates to the nephrology rotation goals and objectives, falls predominantly on the attending. In recognition of their increasing independence and knowledge attainment, second year Fellows may provide formal lectures to residents who rotate on the Nephrology and Hypertension service. On the Consultation service, Fellows may assign inpatients to residents and pre-round on those patients with the resident, but attendings have the final approval for all assignments. Fellows may rarely supervise temporary dialysis vascular access placement by residents only after the Fellow has demonstrated mastery of this skill and such mastery is documented in their record. Fellows and residents may not render decisions about nephrology patient care (including consults, outpatients, and transplants), either written or verbally, without the attending’s verbal or written approval. Hence, fellows may not direct residents to advise primary providers, or their assistants (e.g., nurses, technicians, residents) on medical matters without the direct guidance on such matters by the attending.

MUST CALL ATTENDING LIST:

1) All new consults

2) Any code blue or rapid response called in the dialysis unit

3) All new antibiotics for peritoneal dialysis patients

4) All status changes on new transplant patients (urine output/blood pressure

changes/new medications/critical labs)

5) Call regarding performing any procedure

Faculty Research Interests The research interests of faculty in the Division of Nephrology and Hypertension listed below. This

information, combined with the list of faculty publications in the subsequent section, are intended to help Fellows identify a faculty mentor and research project.

Sharon Adler, M.D., Professor of Medicine and Training Program Director. Dr. Adler’s research

includes basic, clinical, and translational science. Her work includes an elucidation of cellular mechanisms contributing to the development of diabetic nephropathy, and research in glomerulonephritis, and peritoneal dialysis. Bridging observations from the bench to clinical medicine, her participation in two NIH-sponsored research consortia, Nephrotic Syndrome Study Network (NEPTUNE) and CureGN, is contributing to understanding minimal change disease, focal and segmental glomerulosclerosis, IgA nephropathy, and membranous nephropathy on a molecular level. Using clinical and molecular data collected by these consortia, the members are working together to develop personalized precision-medicine approaches to the treatment of glomerular disease.

Lilly Barba, M.D. Associate Professor of Medicine. Dr. Lilly Barba is the Medical Director of the

Renal Transplant Program at Harbor-UCLA Medical Center, overseeing the deceased and living related transplant programs. Her interests include long-term allograft survival and the transplantation of the high immunologic risk patient.

Zar Chan, M.D. Clinical Faculty. Dr. Chan is a faculty member in the Division of Nephrology with

primary activity in the Renal Transplantation program and direct responsibility for the live renal donor program.

Tiane Dai, M.D., Ph.D. Associate Professor of Medicine. Dr. Dai’s research includes basic,

translational, and clinical investigation. Her most recent work addresses the elucidation of biological mechanisms for the preservation of the peritoneal membrane during peritoneal dialysis.

Ramanath Dukkipati, M.D. Associate Professor of Medicine. Dr Dukkipati’s research interests focus

on methods and technology in Interventional Nephrology, pathophysiology and treatment of clinical glomerulonephritis, and renal nutrition.

Joel Kopple, M.D. Professor of Medicine. Dr. Kopple conducts research on nutritional requirements

and nutritional and metabolic disorders in kidney disease and kidney failure. He has recently examined the dietary protein requirements of maintenance hemodialysis patients and the effects of different types of exercise training on exercise capacity, skeletal muscle metabolism, body composition and quality of life in maintenance hemodialysis patients. Dr. Kopple has also recently investigated the interrelationships of disease comprehension and attitudes of these individuals on their adherence to prescribed diets and medicinal intake, and measuring and understanding dialysis patient frailty.

Madeleine Pahl, M.D. Professor of Medicine. Dr. Pahl has published in a wide array of renal disciplines, including, but not limited to renal transplantation, the microbiome in CKD/ESRD, and the genetics of diabetic kidney disease.

Anuja Shah, M.D. Assistant Professor of Medicine. Dr. Shah’s research interests are in phosphorus balance and the effects of phosphorus on morbidity and mortality in CKD and ESRD, and in nutrition in CKD and ESRD.

Jenny Shen, M.D. Assistant Professor of Medicine. Dr. Shen’s research focuses on assessing and improving outcomes in chronic dialysis patients. She has a particular interest in racial and ethnic disparities in care, in peritoneal dialysis, and in medication use. Past projects have included assessing the use and safety of heparin in chronic hemodialysis and identifying determinants of technique failure in peritoneal dialysis. The bulk of her work and expertise is in analyzing large databases using quantitative research methods. However, she is currently expanding her skills in qualitative research methods as well, to include clinical trial design and analysis.

Lili Tong, M.D. Assistant Professor. Dr Tong’s main research interests include the clinical aspects

and pathophysiology of diabetic nephropathy, transplantation, and CKD biomarkers.

Publications by Nephrology Faculty 2010-2018 (Current faculty (black) and fellows (purple) co-authors in BOLD). Original Manuscripts:

1. Bross R, Chandramohan G, Kovesdy CP, Oreopoulos A, Noori N, Golden S, Benner D, Kopple JD, Kalantar-Zadeh K. Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis. 55:885-896, 2010.

2. Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD. Association of dietary

phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol. 5:683-92, 2010.

3. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD: Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:519-530, 2010.

4. Noori N, Kalantar-Zadeh K, Kovesdy CP, Murali SB, Bross R, Nissenson AR, Kopple JD: Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kid Dis 2010 Aug;56(2):338-47. doi:10.1053/j.ajkd.2010.03.022. Epub 2010 Jun 30. PubMed PMID: 20580474; PubMed Central PMCID: PMC2910783.

5. Kim Y, Evangelista LS, Linda R. Phillips LR, Pavlish C, Kopple, JD: The End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ): Testing the psychometric properties in patients receiving Care at Dialysis Centers. Nephrology Nursing Journal, July/August issue 2010Jul-Aug;37(4):377-93. PubMed PMID: 20830945; PubMed Central PMCID: PMC3077091.

6. Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975. PubMed PMID: 20818902.

7. Kalantar-Zadeh K, Golan E, Shohat T, Streja E, Norris KC, Kopple JD. Survival disparities within American and Israeli dialysis populations: learning from similarities and distinctions across race and ethnicity. Semin Dial. 2010 Nov-Dec; 23 (6): 586-94. doi: 10.1111/j.1525-139X.2010.00795.x. Review. PubMed PMID:21175833.

8. Noori N, Kovesdy CP, Dukkipati R, Kim Y, Duong U, Bross R, Oreopoulos A, Luna A, Benner D, Kopple JD, Kalantar-Zadeh K: Survival-predictability of lean vs. Fat mass in men and women undergoing maintenance hemodialysis Am J Clin Nutr 2010 Nov;92(5):1060-70. doi: 10.3945/ajcn.2010.29188. Epub 2010 Sep 15. PubMed PMID: 20844076; PubMed Central PMCID: PMC2954443.

9. Contreras G, Hu B, Astor BC, Greene T, Erlinger T, Kusek JW, Lipkowitz M, Lewis JA, Randall OS, Hebert L, Wright JT Jr, Kendrick CA, Gassman J, Bakris G, Kopple JD, Appel LJ; African-American Study of Kidney Disease, and Hypertension Study Group. Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol. 2010 Dec;21(12):2131-42. doi: 10.1681/ASN.2009121285. Epub 2010 Sep 23. PubMed PMID: 20864686; PubMed Central PMCID: PMC3014026.

10. Wang S, Wilkes MC, Leof EB, Hirschberg R: Non-canonical TGFβ-pathways, mTORC1 and Abl, in Renal interstitial fibrogenesis. Am J Physiol-Renal Physiol 298:F142-F149, 2010.

11. Molnar MZ, Lukowsky L, Streja E, Dukkipati R, Jing J, Nissenson AR, Kovesdy CP, Kalantar-

Zadeh K: Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. Journal of Hypertension; Aug: 2010 Gollapudi P., Yoon, J.W., Gollapudi, S., Pahl, M.V., Vaziri, N.D.: Leukocyte Toll-Like Receptor Expression in End-Stage Kidney Disease Am J Nephrol. 2010 Jan 15;31(3):247-254. [Epub ahead of print]PMID: 20090311

12. Pahl M.V. , Gollapudi S., Sepassi L., Gollapudi P., Elahimehr R., Vaziri N.D.: Effect of End-Stage Renal Disease on B Lymphocytes Subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant 2010 Jan; 25(1):205-12 Epub 2009 Aug 14 PubMed PMID: 19684120.

13. Pahl M.V., Vaziri N.D., Yuen J., Adler S.G.: Upregulation of monocyte/macrophage HGFIN

(Gpnmb/Osteoactivin) expression in end-stage renal disease. Clin J Am Soc Nephrol 2010 Jan;5(1):56-61. Epub 2009 Oct 15. PMID 19833906

14. Adler S., Pahl M., Abboud H., Nicholas S., Ipp E., Seldin M.: Mexican-American admixture

mapping analyses for diabetic nephropathy in type 2 diabetes mellitus. Semin Nephrol. 2010 Mar;30(2):141-9. PubMed PMID: 20347643.

15. Kim, S., Abboud, H., Pahl, M., Tayek, J., Snyder, S., Tamkin, J., Alcorn, H. Ipp, E., Nast, C.,

Elston, R., Iyengar, S. Adler, S.: Examination of association with candidate genes for diabetic nephropathy in a Mexican-American population. Clin J Am Soc Nephrol. 5: 1072-1078, 2010. [Epub ahead of print]PMID: 20299368 [PubMed]

16. Moradi H., Ganji S., Kamanna V., Pahl M.V., Vaziri N.D.: Increased monocyte adhesion-promoting

capacity of plasma in end-stage renal disease-response to antioxidant therapy. Clin Neph. 2010

17. Vaziri N.D., Navab K., Gollapudi P., Moradi H., Pahl M.V., Barton C.H., Fogelman A.M., Navab M.: Salutary effects of Hemodialysis on LDL Pro-Inflammatory and HDL Anti-Inflammatory properties in Patients with ESRD. J Natl Med Assoc. 2011 Jun;103(6):524-33.

18. Igo RP Jr, Iyengar SK, Nicholas SB, Goddard KA, Langefeld CD, Hanson RL,Duggirala R, Divers J, Abboud H, Adler SG, Arar NH, Horvath A, Elston RC, Bowden DW, Guo X, Ipp E, Kao WH, Kimmel PL, Knowler WC, Meoni LA, Molineros J, Nelson RG, Pahl MV, Parekh RS, Rasooly RS, Schelling JR, Shah VO, Smith MW, Winkler CA, Zager PG, Sedor JR, Freedman BI; Family Investigation of Nephropathy and Diabetes Research Group. Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol.;33(5):381-9, 2011 Epub 2011 Mar 31. PubMed PMID: 21454968.

19. Lee HJ, Pahl MV, Vaziri ND, Blake DR. Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD. J Ren Nutr May;22(3):357-64.2012.Epub 2011 Nov 18. PubMed PMID:22100775.

20. Wang S, Hirschberg R: Y-box protein-1 is a transcriptional regulator of BMP7. J Cell Biochem. 112:1130-1137, 2011. .

21. Noori N, Kovesdy CP, Dukkipati R, Feroze U, Molnar MZ, Bross R, Nissenson AR, Kopple JD, Norris KC, Kalantar-Zadeh K. Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation. Am J Nephrol. 2011;33(2):157-67. doi: 10.1159/000323972. Epub 2011 Feb 4. PubMed PMID: 21293117; PubMed Central PMCID: PMC3202917.

22. Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Noori N, Murali SB, Block T, Norris J, Kopple JD, Block G. Design and development of a dialysis food frequency questionnaire. J Ren Nutr. 2011 May;21(3):257-62. doi: 10.1053/j.jrn.2010.05.013. Epub 2010 Sep 15. PubMed PMID: 20833073; PubMed Central PMCID: PMC3047592.

23. Streja E, Kovesdy CP, Molnar MZ, Norris KC, Greenland S, Nissenson AR, Kopple JD, Kalantar-Zadeh K. Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis. 2011 Jun;57(6):883-93. doi:

10.1053/j.ajkd.2010.10.050. Epub 2011 Jan 15. PubMed PMID: 21239093; PubMed Central PMCID: PMC3081903.

24. Noori N, Kovesdy CP, Dukkipati R, and Kalantar-Zadeh: Racial and ethnic differences in mortality

in hemodialysis patients: role of dietary status and nutritional status and inflammation: Am J Nephrol. 2011; 33 (2): 157-67. 2011

25. Dukkipati R, Gautam T, Kalantar-Zadeh K, and Dhamija R: Radiation time decreases with increased number of procedures by the Interventional Nephrologist. Seminars in Dialysis: Jan-Feb; 2011

26. Tyler S. Reynolds, Mohamed Zayed, Karen Kim, Jason Lee, Ramanath Dukkipati and Christian De Virgilio C: A Comparison between Single Stage and Two Stage Brachial Artery –Basilic Vein Fistulas: J Vascular Surgery: Jun; 53(6): 1632-9. Epub 2011 Apr 30.2011

27. Usama Feroze, Ramanath Dukkipati, Csaba P. Kovesdy, and Kamyar Kalantar-Zadeh: Insights into nutritional and inflammatory aspects of low Parathyroid hormone in dialysis patients: J Renal Nutrition: Jan 21(1) 100-4: 2011

28. Feroze U, Noori N, Kovesdy CP, Molnar MZ, Martin DJ, Reina-Patton A, Benner D, Bross R, Norris KC, Kopple JD, Kalantar-Zadeh K. Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc Nephrol. 2011 May;6(5):1100-11. doi: 10.2215/CJN.07690910. Epub 2011 Apr 28. PubMed PMID: 21527646; PubMed Central PMCID: PMC3087777.

29. Noori N, Dukkipati R, Kovesdy CP, Sim JJ, Feroze U, Murali SB, Bross R, Benner D, Kopple JD, Kalantar-Zadeh K. Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis. 2011 Aug;58(2):248-56. doi: 0.1053/j.ajkd.2011.03.017. Epub 2011 Jun 12. PubMed PMID: 21658827; PubMed Central PMCID: PMC3144295.

30. Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, Kalantar-Zadeh K. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011 Sep;58(3):418-28. doi: 10.1053/j.ajkd.2011.03.018. Epub 2011 May 20. PubMed PMID: 21601335; PubMed Central PMCID: PMC3159826.

31. Ricks J, Molnar MZ, Kovesdy CP, Kopple JD, Norris KC, Mehrotra R, Nissenson AR, Arah OA, Greenland S, Kalantar-Zadeh K. Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis. 2011 Oct;58(4):574-82. doi: 10.1053/j.ajkd.2011.03.023. Epub 2011 Jun 12. PubMed PMID: 21658829; PubMed Central PMCID: PMC3183288.

32. Kopple JD, Cheung AK, Christiansen JS, Djurhuus CB, El Nahas M, Feldt-Rasmussen B, Mitch WE, Wanner C, Göthberg M, and Ikizler TA OPPORTUNITYTM: A large-scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrol Dial Transplant. 2011 Dec;26(12):4095-4103. doi:10.1093/ndt/gfr363. Epub 2011 Jul 12. PubMed PMID: 21750157.

33. Phillips L, Dai T, Feldman DL, LaPage J, Adler SG: The renin inhibitor Aliskiren attenuates high glucose induced extracellular matrix synthesis and prevents apoptosis in cultured podocytes. Nephron Exp Nephrol 118:e49-e59, 2011

34. Patel-Chamberlin M, Wang Y, Dai T, Satirapoj B, Wu X, Natarajan R, Nast CC, Hirschberg R,

LaPage J, Watkins R, Nam E, Haq T, and Adler SG: Hematopoietic Growth Factor Inducible Neurokinin-1 (HGFIN): Marker of Injury in Diverse Renal Disease Across Species. Kidney

International 79:1138-48, 2011. doi:10.1038/ki.2011.28

35. Igo RP, Iyengar SK, Nicholas SB, Goddard KAB, Langefeld CD, Hanson RL, Duggirala R, Divers J, Abboud H, Adler SG, et al: Genome-wide linkage scan for diabetic renal failure and albuminuria: The FIND Study. Am J Nephrol 33:381-89, 2011

36. Noori N, Dukkipati R, Kovesdy CP and Kalantar-Zadeh: Dietary Omega-3 fatty acid, Ratio of Omega -6 to Omega -3 intake and survival in Long term Hemodialysis patients: AJKD: June 7: 2011:Epub

37. Tushar J Vachharajani, Shariar Moosavi, Ramanath Dukkipati, Arif Asif: Dialysis Vascular Access Management by Interventional Nephrology Programs at University Medical Centers in the United States: Seminars in Dialysis: Sep-Oct: 2011

38. Reynolds T, Dukkipati R and Chauvapun J: Preoperative regional block enhances operative strategy for arteriovenous fistula creation: Nov-Dec:2011:Journal of Vascular Access

39. Rattanasompatikul M,Feroze U, Molnar M, Dukkipati R, Kovesdy C, Nissenson, Kopple J and Kalantar-Zadeh K: Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients: International Journal of Urology and Nephrology: :Dec 44(6) 2012

40. Lewis MI, Fournier M, Wang H, Storer TW, Casaburi R, Cohen AH, Kopple JD. Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients. J Appl Physiol. 2012 Jan;112(1):72-78. doi: 10.1152/japplphysiol.00556.2011. Epub 2011 Oct 20. PubMed PMID: 22016372; PubMed Central PMCID: PMC3290422.

41. Feroze U, Martin D, Kalantar-Zadeh K, Kim JC, Reina-Patton A, Kopple JD. Anxiety and depression in maintenance dialysis patients: preliminary data of a cross-sectional study and brief literature review. J Ren Nutr. 2012 Jan;22(1):207-10. doi: 10.1053/j.jrn.2011.10.009. Review. PubMed PMID: 22200444.

42. Kim Y, Evangelista LS, Phillips LR, Pavlish C, Kopple JD. Racial/ethnic differences in illness, perceptions in minority patients undergoing maintenance hemodialysis. Nephrol Nurs J. 2012 Jan-Feb;39(1):39-48; quiz 49. PubMed PMID: 22480051; PubMed Central PMCID: PMC3390251.

43. Lee HJ, Pahl MV, Vaziri ND, Blake DR. Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD. J Ren Nutr May;22(3):357-64.2012.Epub 2011 Nov 18. PubMed PMID:22100775.

44. Lee HJ, Meinardi S, Pahl MV, Vaziri ND, Blake DR. Exposure to potentially toxic hydrocarbons and halocarbons released from the dialyzer and tubing set during hemodialysis. Am J Kidney Dis.Oct;60(4):609-16, 2012.Epub 2012 Apr 14. PubMed PMID: 22507911.

45. Bostrom MA, Kao WHL, Man Li M, Abboud HE, Adler SG, Iyengar SK, Kimmel PL, Hanson RL,

Nicholas SB, Rasooly RS, Sedor JR, Coresh J, Kohn OF, Leehey DJ, Thornley-Brown D, Bottinger EP, Lipkowitz MS, Meoni LA, Klag MJ, Lu L, Hicks PJ, Langefeld CD, Parekh RS, Bowden DW, and Barry I. Freedman BI on behalf of the Family Investigation of Nephropathy and Diabetes Research Group: Genetic association and gene-gene interaction analyses in African American dialysis patients with non-diabetic nephropathy. AJKD in 59:210-21, 2012

46. Satirapoj B, Wang Y, Chamberlin MP, Dai T, LaPage J, Phillips L, Nast CC, and Adler SG:

Periostin: Novel tissue and urinary biomarker of progressive renal injury indicative of distal nephron tubular epithelial mesenchymal transition. Nephrol. Dial. Transplant. (2012) 27 (7): 2702-2711. doi:

10.1093/ndt/gfr670

47. Jiwakanon S, Adler S, Mehrotra R: Change in Ankle-Brachial Indices over time and Mortality in Diabetics with Proteinuria. Clinical Nephrology 2012. PMID: 22784559

48. Satirapoj B, Bruhn K, Nast CC, Wang Y, Dai T, LaPage J, Phillips L, Wu X, Natarajan R, and Adler

SG: Oxidized Low-Density Lipoprotein Antigen Transport Induces Autoimmunity in the Renal Tubulointerstitium. American Journal of Nephrology 35(6): 520-30, 2012. PMID: 22653259]

49. Kim Y, Park JC, Molnar MZ, Shah A, Benner D, Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Correlates of low hemoglobin A1c in maintenance hemodialysis patients. Int Urol Nephrol. 2012 Jun 9. [Epub ahead of print] PubMed PMID: 22684796.

50. Molnar MZ, Streja E, Kovesdy CP, Shah A, Huang E, Bunnapradist S, Krishnan M, Kopple JD, Kalantar-Zadeh K. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis. 2012 Jun;59(6):841-848. doi: 10.1053/j.ajkd.2011.12.014. Epub 2012 Feb 4. PubMed PMID: 22305759; PubMed Central PMCID: PMC3532934.

51. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, Desantis TZ, Ni Z, Nguyen TH, Andersen GL. Chronic kidney disease alters intestinal microbial flora. Kidney Int.Feb;83(2):308-15, 2013.Epub 2012 Sep 19. PubMed PMID: 22992469.

52. Supasyndh O, Satirapoj B, Aramwit P, Viroonudomphol D, Chaiprasert A, Thanachatwej V, Vanichakarn S, Kopple JD. Effect of Oral Anabolic Steroid on Muscle Strength and Muscle Growth in Hemodialysis Patients. Clin J Am Soc Nephrol. 2013 Feb;8(2):271-279. doi: 10.2215/CJN.00380112. Epub 2012 Nov 2. PubMed PMID: 23124786; PubMed Central PMCID: PMC3562853.

53. Thameem F, Igo RP Jr, Freedman BI, Langefeld C, Hanson RL, Schelling JR,Elston RC, Duggirala R, Nicholas SB, Goddard KA, Divers J, Guo X, Ipp E,Kimmel PL, Meoni LA, Shah VO, Smith MW, Winkler CA, Zager PG, Knowler WC,Nelson RG,Pahl MV, Parekh RS, Kao WH, Rasooly RS, Adler SG, Abboud HE,Iyengar SK, SedorJR; Family Investigation of Nephropathy and Diabetes Research Group. A Genome-Wide Search for Linkage of Estimated Glomerular Filtration Rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND). PLoS One. 2013 Dec17;8(12):e81888. doi: 10.1371/ journal.pone.0081888. eCollection 2013. PubMed PMID: 24358131; PubMed Central PMCID: PMC3866106.

54. Hatamizadeh P, Ravel V, Lukowsky LR, Molnar MZ, Moradi H, Harley K, Pahl M, Kovesdy CP, Kalantar-Zadeh K. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant. 2013 Nov;28(11):2889-98. doi: 10.1093/ndt/gft411. PubMed PMID:24169614; PubMed Central PMCID: PMC3811063.

55. Molnar MZ, Ichii H, Lineen J, Foster CE 3rd, Mathe Z, Schiff J, Kim SJ, Pahl MV, Amin AN, Kalantar-Zadeh K, Kovesdy CP. Timing of return to dialysis in patients with failing kidney transplants. Semin Dial. 2013 Nov-Dec;26(6):667-74. doi: 10.1111/sdi.12129. Epub 2013 Sep 9. PubMed PMID: 24016076.

56. Park J, Jin DC, Molnar MZ, Dukkipati R, Kim YL, Jing J, Levin NW, Nissenson AR, Lee JS, Kalantar-Zadeh K: Mortality Predictability of Body Size and Muscle Mass Surrogates in Asian vs White and African American Hemodialysis Patients. Mayo Clinic Proceedings: April:2013

57. Sharma T, Park J, Dukkipati R and Kalantar-Zadeh K: Effect of age and dialysis vintage on obesity-mortality paradox in long- term hemodialysis patients. American Journal of Kidney Disease: Oct : 2013

58. Dukkipati R: Association of vascular access type with inflammatory markers level in maintenance

hemodialysis patients: Seminars in Dialysis: Oct: 2013

59. Rattanasompattikul M, Molnar MZ, Lee ML, Dukkipati R, Bross R, Jing J, Kim Y, Voss AC, Benner D, Feroze U, Macdougall IC, Tayek JA, Norris KC, Kopple JD, Unruh M, Kovesdy CP, Kalantar-Zadeh K: Anti-Inflammatory and anti-oxidative nutrition in hypoalbuminemic dialysis patients (AIONID) study results of the pilot-feasibility, double blind randomized, placebo controlled trial: J Cachexia Sarcopenia Muscle: 2013 :Sep 20 ( E pub ahead of print)

60. Gadegbku CA, Gipson D. Holzman L, Ojo AO, Song P, Barisoni L,Sampson MG, Kopp J, Lemley KV, Nelson P,Lienczewski C, Adler S, et al: Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multi-disciplinary approach. Kidney International 83:749–756, 2013. doi:10.1038/ki.2012.428.

61. Gangaputra SS, Lovato J, Hubbard L, Davis MD, Esser BA, Ambrosius W, Chew EY, Greven C, Perdue LH, Wong WT, Condren A, Wilkinson CP, CG, Adler S and Danis RP for the ACCORD Eye Research Group: Comparison of Standardized Clinical Scale with Fundus Photograph Grading for the assessment of Diabetic Retinopathy and Diabetic Macular Edema. Retina. 2013 Jul-Aug;33(7):1393-9. doi: 10.1097/IAE.0b013e318286c952.

62. Tiane Dai, Wang Y, Nayak A, Nast CC, Quang L, LaPage J, Andalibi A, and Adler SG: Janus Kinase Signaling Activation in the Mediation of Peritoneal Inflammation and Injury in vitro and in vivo in Response to Peritoneal Dialysate. Kidney International (9 July 2014) doi:10.1038/ki.2014.209

63. Shah A, Miller CJ, Nast CC, Adams MD, Truitt B, Tayek JA Tong L, Mehtani P, Monteon F, Sedor JR, Clinkenbeard EL, White K, Mehrotra R, LaPage J, Dickson P, Adler SG, Iyengar SK: Severe Vascular Calcification and Tumoral Calcinosis in a Family with Hyperphosphatemia: An FGF23 Mutation Identified by Exome Sequencing. Nephrol. Dial. Transplant. (2014) doi: 10.1093/ndt/gfu324

64. Wong J, Piceno YM, Desantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD. Am J Nephrol.2014 Mar 8;39(3):230-237. [Epub ahead of print] PubMed PMID: 24643131.

65. Shen JI, Mitani AA, Chang TI, Winkelmayer WC. (2013). Use and safety of heparin-free hemodialysis in the USA. Nephrology Dialysis Transplantation, 28(6), 1589-1602. PMCID: PMC3888305

66. Shen JI, Montez-Rath ME, Erickson KF, Winkelmayer WC. (2014). Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older U.S. patients. Pharmacoepidemiology and Drug Safety, 23(5), 515-25. PMCID: PMC4022350

67. Shen JI, Mitani AA, Winkelmayer WC. (2014). Heparin use in hemodialysis patients following gastrointestinal bleeding. American Journal of Nephrology, 40(4), 300-7. PMCID: PMC4246045

68. Chang IT, Montez-Rath ME, Shen JI, Solomon MD, Chertow GM, Winkelmayer WC. (2014). Thienopyridine use after coronary stenting in low income patients receiving maintenance dialysis enrolled in Medicare part D. Journal of the American Heart Association, 3(5), e001356. PMCID: PMC4323824

69. Lenihan CR, Montez-Rath ME, Shen JI, Scandling JD, Turakhia M, Chang TI, Winkelmayer WC. (2014). Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation. Nephrology Dialysis Transplantation, 30(2), 321-9. PMCID: PMC4318917

70. Satirapoj B, Adler SG: Comprehensive approach to diabetic nephropathy. Kidney Res Clin Pract. 2014 Sep;33(3):121-31. doi: 10.1016/j.krcp.2014.08.001.

71. Sudha Iyengar, John R. Sedor, Barry I. Freedman, W. H. Linda Kao (deceased), Matthias Kretzler, Benjamin J. Keller, Hanna E. Abboud (deceased), Sharon G. Adler, et al: Genome-wide association and trans-ethnic meta-analysis for advanced diabetic kidney disease: Family Investigation of Nephropathy and Diabetes (FIND). PLoS Genet. 2014 Aug 7;10(8):e1004517. doi: 10.1371/journal.pgen.1004517

72. Hogan MC, Lieske JC, Lienczewski CC, Nesbitt LL, Wickman LT, Heyer CM, Harris PC, Ward CJ, Sundsbak JL, Manganelli L, Ju W, Kopp JB, Nelson PJ, Adler SG, Reich HN, Holzman LB, Kretzler M, Bitzer M: Strategy and rationale for urine collection protocols employed in the NEPTUNE study.

BMC Nephrol. 2015 Nov 17;16(1):190. doi: 10.1186/s12882-015-0185-3. PMID: 26577187

73. Shen JI, Montez-Rath, ME, Lenihan CR, Turakhia M, Chang TI, Winkelmayer WC. (2015). Outcomes after warfarin initiation in hemodialysis patients with newly diagnosed atrial fibrillation. American Journal of Kidney Diseases, 66(4), 677-88. PMCID: PMC4584203

74. Moradi H, Abhari P, Streja E, Kashyap ML, Shah G, Gillen D, Pahl MV, Vaziri ND, Kalantar-Zadeh K. Association of Serum Lipids with Outcomes in Hispanic Hemodialysis Patients of the West versus East Coasts of the United States. Am J Nephrol. 2015 May 30;41(4-5):284-295. [Epub ahead of print] PubMed PMID:26044456.

75. Rhee C, Dukkipati R, and Kamyar Kalantar-Zadeh : Adiponectin and its relation to Hemodialysis access and Inflammation: American Journal of Kidney Disease:2015:August: Volume 66, Issue 2, Pages 313–321

76. Kim J, Gifford E, Dukkipati R, and de Virgilio C: Increased use of brachiocephalic arteriovenous fistulas improves functional primary patency: Journal of vascular surgery:2015:Aug

77. Shah AP, Shen JI, Wang Y, Tong L, Pak Y, Andalibi A, LaPage JA, Adler SG: Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. PLoS One. 2016 Mar 28;11(3):e0152357. doi: 10.1371/journal.pone.0152357

78. Kalantar-Zadeh K, Moore LW, Tortorici AR, Chou JA, St-Jules DE, Aoun A, Rojas-Bautista V, Tschida AK, Rhee CM, Shah AA, Crowley S, Vassalotti JA, Kovesdy CP. North American experience with Low protein diet for Non-dialysis-dependent chronic kidney disease. BMC Nephrol. 2016 Jul 19;17(1):90. Doi: 10.1186/s12882-016-0304-9. PubMed PMID: 27435088; PubMed Central

79. Shah A, Bross R, Shapiro BB, Morrison G, Kopple JD. Dietary energy requirements in relatively healthy maintenance hemodialysis patients estimated from long-term metabolic studies. Am J Clin Nutr. 2016 Mar;103(3):757-65. doi: 10.3945/ajcn.115.112995. Epub 2016 Feb 10. PubMed PMID: 26864370

80. Shen JI, Saxena AB, Montez-Rath ME, Chang TI, Winkelmayer WC. (2016). Angiotensin-

Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Use and Cardiovascular Outcomes in

Patients Initiating Peritoneal Dialysis. Nephrology Dialysis Transplantation. Published online ahead of print April 13, 2016. doi: 10.1093/ndt/gfw053

81. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, et al: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016 Jan 2;12(1):1-222. PMID:26799652

82. Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M: Complete Remission in the Nephrotic Syndrome Study Network. Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10

83. Williams RC, Elston RC, Kumar P, Knowler WC, Abboud HE, Adler S, Bowden DW, Divers J, Freedman BI, Igo RP Jr, Ipp E, Iyengar SK, Kimmel PL, Klag MJ, Kohn O, Langefeld CD, Leehey DJ, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Rotter JI, Schelling JR, Sedor JR, Shah VO, Smith MW, Taylor KD, Thameem F, Thornley-Brown D, Winkler CA, Guo X, Zager P, Hanson RL; FIND Research Group: Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND). BMC Genomics. 2016 May 4;17:325. doi: 10.1186/s12864-016-2654-x

84. Hogan MC, Reich HN, Nelson PJ, Adler SG, Cattran DC, Appel GB, Gipson DS, Kretzler M, Troost JP, Lieske JC: The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases. Kidney Int. 2016 Nov;90(5):1080-1089. doi: 10.1016/j.kint.2016.06.020. Epub 2016 Aug 12

85. Parsa A, Kanetsky PA, Xiao R, Gupta J, Mitra N, Limou S, Xie D, Xu H, Anderson AH, Ojo A, Kusek JW, Lora CM, Hamm LL, He J, Sandholm N, Jeff J, Raj DE, Böger CA, Bottinger E, Salimi S, Parekh RS, Adler SG, Langefeld CD, Bowden DW; FIND Consortium., Groop PH, Forsblom C, Freedman BI, Lipkowitz M, Fox CS, Winkler CA, Feldman HI; and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators: Genome-Wide Association of CKD Progression: The Chronic Renal Insufficiency Cohort Study. J Am Soc Nephrol. 2017 Mar;28(3):923-934. doi: 10.1681/ASN.2015101152. Epub 2016 Oct 11

86. Manera KE, Tong A, Craig JC, Brown EA, Brunier G, Dong J, Dunning T, Mehrotra R, Naicker S, Pecoits-Filho R, Perl J, Wang AY, Wilkie M, Howell M, Sautenet B, Evangelidis N, Shen JI, Johnson DW; SONG-PD Investigators. Standardized Outcomes in Nephrology-Peritoneal Dialysis (SONG-PD): Study Protocol for Establishing a Core Outcome Set in PD. Perit Dial Int. 2017 Nov-Dec;37(6):639-647. doi: 10.3747/pdi.2017.00022. Epub 2017 Aug 1. PubMed PMID: 28765167; PubMed Central PMCID: PMC5878088.

87. Tong A, Gill J, Budde K, Marson L, Reese PP, Rosenbloom D, Rostaing L, Wong G, Josephson MA, Pruett TL, Warrens AN, Craig JC, Sautenet B, Evangelidis N, Ralph AF, Hanson CS, Shen JI, Howard K, Meyer K, Perrone RD, Weiner DE, Fung S, Ma MKM, Rose C, Ryan J, Chen LX, Howell M, Larkins N, Kim S, Thangaraju S, Ju A, Chapman JR; SONG-Tx Investigators. Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops. Transplantation. 2017 Aug;101(8):1887-1896. doi: 10.1097/TP.0000000000001774. PubMed PMID: 28737661; PubMed Central PMCID: PMC5604246.

88. Kopple JD, Shapiro BB, Feroze U, Kim JC, Zhang M, Li Y, Martin DJ. Hemodialysis treatment

engenders anxiety and emotional distress. Clin Nephrol. 2017 Oct; 88(10):205-217. doi: 10.5414/CN109112. PubMed PMID: 28818189.

89. Miyata KN, Shen JI, Nishio Y, Haneda M, Dadzie KA, Sheth NR, Kuriyama R, Matsuzawa C, Tachibana K, Harbord NB, Winchester JF. Patient knowledge and adherence to maintenance hemodialysis: an International comparison study. ClinExp Nephrol. 2018 Aug;22(4):947-956. doi: 10.1007/s10157-017-1512-8. Epub 2017 Nov 28. PubMed PMID: 29185127; PubMed Central PMCID: PMC5972057.

90. Ku E, Kopple JD, Johansen KL, McCulloch CE, Go AS, Xie D, Lin F, Hamm LL, HeJ, Kusek JW, Navaneethan SD, Ricardo AC, Rincon-Choles H, Smogorzewski M, Hsu CY; CRIC Study Investigators. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis. 2018 May; 71(5):657-665. doi: 10.1053/j.ajkd.2017.09.015. Epub 2017 Dec 6. PubMed PMID: 29217305; PubMed Central PMCID: PMC5915916.

91. Shen JI, Hercz D, Barba LM, Wilhalme H, Lum EL, Huang E, Reddy U, Salas L,Vangala S, Norris KC. Association of Citizenship Status With Kidney Transplantation in Medicaid Patients. Am J Kidney Dis. 2018 Feb; 71(2):182-190.doi: 10.1053/j.ajkd.2017.08.014. Epub 2017 Nov 8. PubMed PMID: 29128413; PubMed Central PMCID: PMC5794566.

92. Kistler BM, Benner D, Burrowes JD, Campbell KL, Fouque D, Garibotto G, Kopple JD, Kovesdy CP, Rhee CM, Steiber A, Stenvinkel P, Ter Wee P, Teta D, Wang AYM, Kalantar-Zadeh K. Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018 Jan;28(1):4-12. doi: 10.1053/j.jrn.2017.10.003. PubMed PMID: 29249295.

93. Tuttle KR, Brosius FC 3rd, Adler SG, Kretzler M, Mehta RL, Tumlin JA, Tanaka Y, Haneda M, Liu J, Silk ME, Cardillo TE, Duffin KL, Haas JV, Macias WL, Nunes FP, Janes JM JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. Nephrol Dial Transplant. 2018 Feb 22. doi: 10.1093/ndt/gfx377. PMID: 29481660

94. Gipson DS, Selewski DT, Massengill SF, Modes MM, Desmond H, Lee L, Kamil E, Elliott MR,

Adler SG, Oh G, Lafayette RA, Gipson PE, Sinha A, Bagga A, Pesenson A, Courtlandt C, Spino C, Eikstadt R, Pitter R, Attalla S, Waldo A, Winneker R, Carlozzi NE, Troost JP, Smokler I, Stone M: NephCure Accelerating Cures Institute: A Multidisciplinary Consortium to Improve Care for Nephrotic Syndrome. Kidney Int Rep. 2017 Nov 28;3(2):439-446. doi: 10.1016/j.ekir.2017.11.016. eCollection 2018 Mar. PMID: 29725648

95. Kopple JD, Fouque D. Pro: The rationale for dietary therapy for patients with advanced chronic kidney disease. Nephrol Dial Transplant. 2018 Mar 1;33(3):373-378. doi: 10.1093/ndt/gfx333. PubMed PMID: 29471458.

96. Miyata KN, Nast CC, Dai T, Dukkipati R, LaPage JA, Troost JP, Schurgers LJ, Kretzler M, Adler SG.: Renal matrix Gla protein expression increases progressively with CKD and predicts renal outcome. Exp Mol Pathol. 2018 Jul 6; 105(1):120-129. doi: 10.1016/j.yexmp.2018.07.001. [Epub ahead of print] PMID: 29981754

Chapters/Reviews//Editorials/Letters/Proceedings:

1. Wang S, Mitu G, Hirschberg R: Osmotic polyuria: An overlooked mechanism in diabetic

nephropathy. Nephrol Dial Transpl 23:2167-2172, 2008.

2. Mitu G, Hirschberg R: BMP7 in Chronic Kidney Disease. Front Biosci 13:4726-4739, 2008.

3. Adler SG and Nast CC: Thrombotic Microangiopathies. Kidney Disease Primer. 2008

4. Hirschberg R: The third vasculature gets attention. Cardiovasc Res. 80:324-325, 2008.

5. Hirschberg R: Glomerular hyperfiltration in sickle cell disease. Clin J Am Soc Nephrol 5: 748-749,

6. Hirschberg R: The third vasculature gets attention. Cardiovasc Res. 80:324-325, 2008.

7. Dukkipati R, Kopple JD ; Causes and prevention of protein –energy wasting in chronic kidney failure JD Seminars in Nephrology; 2009 Jan 1; 39-49 4.

8. Dukkipati R, Kamyar Kalantar-Zadeh and Kopple JD; Is there a role for IDPN in dialysis patients? Review of: AJKD: Feb 2010:

9. Dukkipati R, Kopple JD; Dietary Protein intake in advanced kidney disease and Dialysis: Seminars in Dialysis; July-Aug: 2010

10. Kalantar-Zadeh K, Shah A, Dukkipati R and Kovesdy CP: Kidney Bone Disease and Mortality in CKD; revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals; Kidney International 78, S10–S21; 2010

11. Hirschberg R: Glomerular hyperfiltration in sickle cell disease. Clin J Am Soc Nephrol 5: 748-749, 2010.

12. Adler SG: Novel Kidney Injury Biomarkers. Journal of Renal Nutrition, Vol 20, No 5S (September), 2010: pp S15–S18

13. Adler SG, Pahl M, Abboud H, Nicholas S, Ipp E, Seldin: Mexican-American admixture mapping

analyses for diabetic nephropathy in Type 2 diabetes mellitus. Seminars in Nephrology 30:1141-49, 2010

14. Park J, Hirschberg R: Hormones and the Kidney. In: Wass J and Shalet S (Edits): Oxford Text Book of Endocrinology and Diabetes, 2nd Edition, Oxford University Press, Oxford, UK, 2011

15. Mehrotra R, Kalantar-Zadeh K, Adler S: Assessment of Glycemic Control in Diabetic Dialysis Patients:Glycosylated Hemoglobin or Glycated Albumin? CJASN 6:1520-22, 2011

16. Dukkipati R, Christian De Virgilio, Tyler Reynolds and Dhamija R: Outcomes of Brachial artery-Basilic vein fistulas: Seminars in Dialysis Mar-Apr; 2011

17. Thameem F, Abboud H, Adler SG: How do genetic and environmental factors interact in

diabetic nephropathy? Diabetes Management 2(5):361-4, 2012

18. Hirschberg R: Renal complications from bisphosphonate treatment. Curr Opin Supp Palliat Care 6:342-347, 2012.

19. Hirschberg R: Drug-nutrient interactions in renal failure. In: Kopple J, Massry S and Kalantar-Zadeh K: Nutritional Management of Renal Disease. Third Edition. Elsevier, New York, 2012

20. Glassock R and Dukkipati R: What are the best biomarkers and definitions of Chronic Kidney

Disease? : Cardiovascular risk reports; Jan: 2012

21. Dukkipati R, Peck M, Tammewar G and McAllister T: Biological Grafts: State of the Art: Seminars in Dialysis International : March,26(2) 2013

22. Thameem F, Kawalit IA, Adler SG, Abboud HE: Susceptibility gene search for nephropathy and related traits in Mexican Americans. Molecular Biology Reports 40:5769, 2013

23. Adler SG and Nast CC: Thrombotic Microangiopathies. Kidney Disease Primer, Sixth edition.

Elsevier Saunders. pages 244-52. 2013

24. Hirschberg R: Kindlin-2: A new player in renal fibrogenesis. J Am Soc Nephrol 24:1339-1340, 2013.

25. Dukkiapti R: Nutritional Management of Renal Disease (textbook), Chapter: Intradialytic Parenteral Nutrition: 2014

26. Dukkipati R: Interventional Nephrology (textbook), Chapter: Cephalic Arch Stenosis:2014

27. Dukkipati R: Clinician Textbook for Hemodialysis Vascular Access (textbook), Chapter: Stent Migration in Hemodialysis Vascular Access: 2014

28. Tong LL, Adler SG. Prevention and Treatment of Diabetic Nephropathy. In: Feehally J (editor), Floege J (editor), Johnson RJ (editor). Comprehensive Clinical Nephrology. 5th edition. 2014

29. Satirapoj B and Adler SG: Comprehensive approach to diabetic nephropathy. Kidney Research and Clinical Practice. 2014.

30. Pahl MV, Vaziri ND. Immune Function in CKD. In: Chronic Renal Disease. Elsevier, 2014

31. Vaziri ND, Zhao YY, Pahl MV. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant. 2015 Apr 16. pii:gfv095. Review. PubMed PMID: 25883197

32. Pahl MV, Vaziri ND. The Chronic Kidney Disease-Colonic Axis. Semin Dial. 2015 Apr 9. doi: 10.1111/sdi.12381. [Epub ahead of print] PubMed PMID: 25855516.

33. Satirapoj B and Adler SG: Prevalence and Management of Diabetic Nephropathy in Western Countries. Kidney Diseases. 2015. DOI: 10.1159/000382028

34. Shah AP, Kalantar-Zadeh K, Kopple JD. Is There a Role for Ketoacid Supplements in the Management of CKD? Am J Kidney Dis. 2015 Feb 12. pii: S0272-6386(14)01475-9

35. Dukkipati R, Lee L and Atray N: Outcomes of Cephalic Arch Stenosis with and without Stent placement in Hemodialysis Patients: Seminars in Dialysis:2015:Jan- Feb

36. Dukkipati R: Handbook of Hemodialysis (textbook). Editors: Nissenson and Fine. Chapter: Intra Dialytic Parenteral Nutrition, 2016

37. Tong L, Adler SG.:Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2018 Feb 7;13(2):335-338. doi: 10.2215/CJN.04650417. Epub 2017 Oct 18. PMID: 29046291

38. Hanafusa N, Lodebo BT, Shah A, Kopple JD. Is There a Role for Diaphoresis Therapy for Advanced Chronic Kidney Disease Patients? J Ren Nutr. 2017 Sep; 27(5):295-302. doi: 10.1053/j.jrn.2017.04.008. Epub 2017 Jun 28. Review. PubMed PMID: 28668284.

39. Tong LL, Adler SG, Wanner,C: Prevention and Treatment of Diabetic Nephropathy. In: Feehally J (editor), Floege J (editor), Johnson RJ (editor). Comprehensive Clinical Nephrology. 6th edition. 2018

40. Tong L, Adler SG: Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers. Postgrad Med. 2018 May;130(4):381-393. doi: 10.1080/00325481.2018.1457397. Epub 2018 Apr 18. PMID: 29667921

16. Nephrology Fellows previous ten years: Fellow Name

Year in Program

Board Certified Internal Medicine

Board Certified Nephrology

Medical School

Residency Current Position

Parag Mehtani

2009-2011 2008 2011 Ross University Maricopa Hospital Private Practice

Harmanjit Singh

2009-2011 2007 2012 Maulana Azad Medical College, India

New York Methodist Hospital

Private Practice

Uttam Reddy 2009-2011 2009 2013 New York Medical College Harbor-UCLA Assistant Professor, UC Irvine

Sevag Balikian

2009-2011 2012 2013 Ross University UCLA-Kern Medical Center

Private Practice

Sapna Patel 2009-2011 2011 2012 Jefferson Medical College Cedars-Sinai Private Practice

Lan Quang 2009-2011 2010 2012 Dexel University College of Medicine

Thomas Jefferson University Hospital

Private Practice

Tiane Dai 2011-2013 2011 2013 Hunan Medical University St Mary Medical Center, Long Beach

Associate Professor, Harbor-UCLA

James Tomas

2012-2014 2011 2015 Ross University West Suburban Medical Center Chicago

Private Practice

Mahdi Yazdany

2012-2014 2012 2014 Islamic Azad University Good Samaritan of Maryland

Private Practice

Fharak Maa 2012-2014 2012 2015 University Auto De Baja California

Alameda County Medical Center

Private Practice

Adnan Khan 2012-2014 2015 2016 Deccan College of Medical Sciences, Hyderabad

St Louis University, MO (Med/Peds)

Private Practice

Luani Lee 2012-2014 2012 2015 University of California, Davis Harbor-UCLA Private Practice

Christopher Woehrstein

2013-2015 2012 2015 Geisel School of Medicine at Dartmouth

Harbor-UCLA Private Practice

Arashdeep Poonia

2014-2016 2013 2016 Temple University, Philadelphia Albert Einstein College of Medicine, Montefiore Medical Center

Private Practice

Zar Che Chan

2014-2016 2014 2016 University of Medicine 1, Myanmar

North Shore Long Island Jewish, Forest Hills

Academic practice, Harbor-UCLA

Charles Nguyen

2014-2016 2014 2016 Chicago Medical School St Mary Medical Center, Long Beach

Private Practice

Krishi Chanduri

2014-2016 2010 2016 Rosalind Franklin University of Medicine and Science

Harbor-UCLA Private Practice

Kana Miyata 2014-2016 2014 2016 Tokyo Medical and Dental University School of Medicine

Beth Israel, NYC Researcher University Montreal

Taurino Avelar

2015-2017 2015 2017 University of Nevada Kaiser Sunset Private Practice

Chonlada Chivangkul

2016-2018 2016 Eligible 2018 Chiang Mai University Faculty of Medicine School of Medicine

Coney Island Hospital Private Practice

Hashim Mapara

2016-2018 2009 Eligible 2018 Dow Medical College, University of Karachi

Brookdale Hospital, Brooklyn, NY

Part-time Private practice; Part-time academic practice

Sandhya Kommana

2016-2018 2010 Eligible 2018 Guntur Medical College/NTR University of Health

Baystate Medical Center, MA

Private Practice

Joseph De Leon

2016-2018 2011 Eligible 2018 Univeristy of Santo Tomas Faculty of Medicine and

Atlanticare Regional Medical Center, Atlantic

Group Practice

Surgery City, NJ

Ramprasad Kandavar

2016-2018 2005, Int Med 2007, Geriatrics

Eligible 2018 Bangalore University Oklahoma University Health Science Center (Internal Medicine and Geriatrics)

Private Practice

Alexander Sweidan

7/1/17 – 7/31/17

2017 Withdrew Poznan University of Medical Sciences Center for Medical Education in English, Poland

St. Mary Medical Center, Long Beach, CA

Critical Care fellowship, USC

Rana Sandhu

7/1/17 – 6/30/18

2017 Eligible 2019 Sri Guru Ram Das Institute of Medical Sciences and Research, India

Northwell Health Long Island Jewish Forest Hills Hospital, NY

2nd yr Nephrology fellow, VCU

Sami Akram 1/4/18 - present

1996, Internal Medicine 2012, Nuclear Medicine 2017, Infectious Diseases Licensed Ultra-sonographer

Eligible 2020 Osmania Medical College, India Nassau University Medical Center, East Meadow, NY

Current fellow

Joseph Doan 7/1/18 - present

Eligible 2018 Eligible 2020 Medical College of Wisconsin Kaiser Permanente Santa Clara, CA

Current fellow

Karid Nieves-Borrero

7/1/18 - present

Eligible 2018 Eligible 2020 Univeristy of Puerto Rico School of Medicine

University District Hospital, San Juan, Puerto Rico

Current fellow

Iryna Patel 7/1/18 - present

Eligible 2018 Eligible 2020 O.O. Bogomolets National Medical University, Kyiv, Ukraine

Brookdale University Hospital and Medical Center, Brooklyn, NY

Current fellow

Revised: 10/1/18